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Abstract
Breast cancer is the second most diagnosed cancer in women, estimated to affect 1 in 8 women
during their lifetime. About 10% to 20% of new breast cancer cases are diagnosed with locally
advanced breast cancer (LABC). LABC tumors are usually larger than 5 cm and/or attached to
the skin or chest wall. It has been reported that when such cases are treated with surgery alone,
metastasis and mortality rates are high, especially where skin involvement or attachment to the
chest wall is extensive. As such, efficient treatment for this kind of breast cancer includes
neoadjuvant chemotherapy (NAC) to shrink the tumor and detach it from the chest wall
followed by surgery. Several studies have shown that there is a strong correlation between
response to NAC and improved treatment outcomes, including survival rate. Unfortunately,
30% to 40% of patients do not respond to chemotherapy, hence losing critical treatment time
and resources. Predicting a patient’s response at the early stages of treatment can help
physicians make informed decisions about whether to continue the treatment or use an
alternative treatment if a poor response is predicted. Such early and accurate response
prediction can shorten the wasted time and reduce resources dedicated to patients while they
endure significant side effects. Therefore, it is important to identify this group of non-responder
patients as early as possible so that they can be prescribed alternative treatments. Current
methods for evaluating LABC response to NAC are based on changes in tumor dimensions
using physical examinations or standard anatomical imaging. Such changes may take several
months to be detectable. Studies have shown that there is a correlation between LABC response
to NAC and tumor softening. In other words, in contrast to responder patients where tumor
stiffness generally decreases in response to NAC, in non-responder patients the stiffness of the
tumor increases or does not change significantly. As such, a reliable and widely available breast
elastography technique can have a major impact on the effective treatment of LABC patients.
In this study, we first develop a tissue-mechanics-based method for improving the accuracy of
ultrasound elastography. This method consists of 3 steps that are applied to the displacement
fields generated from conventional motion-tracking methods. These three steps include:
smoothing the displacement fields using Laplacian filtering, enforcing tissue incompressibility
equation to refine the displacement fields, and finally enforcing tissue compatibility equation
to refine the strain fields. The method was promising through validation using in silico,
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phantom, and in vivo studies. A huge improvement of this method compared to other motiontracking methods is its ability in generating lateral displacement with high accuracy. This
becomes especially important when the displacement and strain fields are used as inputs to an
inverse-problem framework for calculating the stiffness characteristics of tissue, for example,
Young’s modulus. We then use this enhanced ultrasound elastography technique to assess the
response of LABC patients to NAC based on monitoring the stiffness of their tumors
throughout the chemotherapy course. Our results show that this method is effective in
predicting patients’ responses accurately as early as 1 week after NAC initiation.

Keywords
Biomechanics, Breast Cancer, Chemotherapy, Diagnosis, Early Detection, Elastography,
Finite Element Modeling, Full Inversion, Iterative Method, Locally Advanced Breast Cancer,
Motion-tracking Method, Neoadjuvant Chemotherapy, Optimization, Regularization, Tumor
Response Evaluation, Ultrasound Imaging, Ultrasound Elastography
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Summary for Lay Audience
Breast cancer is the most diagnosed type of cancer and the second leading cause of cancerrelated deaths in women. In 2020, it was estimated that more than 27,000 new invasive breast
cancer cases to be diagnosed in women while 5100 women were predicted to die from this
disease in Canada. Breast cancer tumor development is associated with considerable
interaction with stromal cells, extracellular matrix, and connective tissue. As such, breast
cancer is associated with significant changes in tissue biomechanical properties.
Out of patients struck with breast cancer, 10% to 20% are diagnosed with locally advanced
breast cancer (LABC). Current treatments for LABC include neoadjuvant chemotherapy
(NAC), followed by mastectomy or lumpectomy. The NAC is administrated to shrink the
tumor and detach it from the chest wall so that it becomes operable. While the response to
chemotherapy has demonstrated a strong correlation with overall treatment outcomes and
patients’ survival, unfortunately, 30% to 40% of patients do not respond to chemotherapy.
Therefore, it is important to identify this group of non-responder patients as early as possible
so that they can be prescribed alternative treatments. The current methods for evaluating LABC
response to NAC is based on changes in tumor dimensions using physical examinations or
standard anatomical imaging. However, changes in tumor size after NAC may take several
months to be detectable, and in some cases, they do not become apparent despite a positive
histological outcome. Studies have shown that, generally, there is a correlation between LABC
response to NAC and tumor softening. In other words, in contrast to responder patients where
tumor stiffness generally decreases in response to NAC, in non-responder patients the stiffness
of tumor increases or does not change significantly.
Ultrasound (US) Elastography is a non-invasive imaging modality developed for tissue
stiffness mapping. This imaging modality can potentially be used as a clinically viable
diagnostic tool to detect and characterize mechanical properties of breast cancer tumors
including stiffness changes over time. The primary purpose of our long-term study is to
develop novel methods for US elastography to improve its accuracy and reliability in the
clinical setting. Once developed, we applied the methods using clinical data acquired through
an observational study on LABC patients who underwent NAC. Results obtained from this
study are used to assess the efficacy of our enhanced US elastography technique in evaluating
iv

LABC patient response soon after the start of NAC. According to these results, our method is
successful in assessing this response as soon as 1 week after the start of NAC.
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Chapter 1

1

Introduction

1.1 Background and Motivation
1.1.1

Breast Cancer

The most common cancer diagnosed in Canadian women is breast cancer (excluding nonmelanoma skin cancers) [1]. This type of cancer has the second-highest mortality rate
among cancer-affected women, after lung and bronchus [2]. While it can also occur in men,
its incidence rate in the male sex is low [1]. 27,700 Canadian women were estimated to be
diagnosed with breast cancer in 2021, representing 25% of all women’s cancer cases.
Furthermore, in the same year, it was estimated that breast cancer would claim the lives of
5,400 Canadian women, 13% of all cancer deaths among women [1]. The daily estimation
of new breast cancer cases and deaths from breast cancer are 76 and 15 Canadian women,
respectively. Additionally, Canadian men were estimated to develop breast cancer at a rate
of 260 per year with 55 of them dying from the disease in 2021 [1].
The female breast contains three different types of tissue: fibrous (or connective) tissue,
glandular tissue, and fatty tissue [3]. The proportion of each of these tissue types differs
from person to person. If a person has dense breasts, it implies that she has more fibrous
and glandular tissue and less fatty tissue. The fibroglandular tissue in the breast includes
15 to 20 lobes, each including several lobules, where milk is made. Lobules are connected
to the ducts that lead out to the nipple.
Breast cancers are mostly originated from the cells that make up the lobules and terminal
ducts. This happens when the cells proliferate and divide uncontrollably, resulting in a
mass of tissue known as a tumor. Cancerous cells can be either in situ or invasive based on
whether they penetrate through the basement membrane. Lobular carcinoma in situ (LCIS),
a type of cancer that only develops in the female breast, originates from the terminal duct
lobular units, whereas, in ductal carcinoma in situ (DCIS) the cancerous cells start
developing inside a milk duct in the breast [4]. In both of these cancer types, the cancer
cells are confined to the area where they initially formed. On the other hand, in invasive
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ductal and lobular carcinoma (IDC and ILC), the cancerous cells can spread into the breast
tissue and nearby lymph nodes and beyond. Invasive breast cancers can have different
features and develop in different ways. While less common than other forms of breast
cancer, these cancers can be more serious.
Receptors are a special class of proteins that are attached to specific substances in the blood.
All normal breast cells, as well as some breast cancer cells, have estrogen and progesterone
receptors which are needed for the cells to grow. One type of categorizing breast cancer is
based on the protein receptors that the breast cancer cells have. They may have estrogen
receptors (ER-positive or ER+), progesterone receptors (PR-positive or PR+), human
epidermal growth factor receptor (HER2-positive or HER2+), or a combination of them.
HER2 protein has a great role in growing cancer cells. If the breast cancer cells have any
of the above-mentioned receptors, hormone therapy can be prescribed. Inflammatory breast
cancer is another aggressive type of invasive breast cancer where cancer cells block the
lymph vessels in the skin, making the breast appear red and swollen. This rare condition
accounts for only 1% to 5% of all breast cancer cases.
When a breast cancer has advanced locally but has not yet spread beyond the breast and
local lymph nodes, it is called locally advanced breast cancer (LABC). LABC is
characterized by large breast tumors (i.e., more than 5 centimeters in diameter), cancers
that include the skin of the breast or the underlying muscles of the chest, or any size of
tumor with multiple local lymph nodes involvement. Inflammatory breast cancer is also
considered as LABC [5]. LABC does not include breast cancers that have distant metastatic
spread [6]. Overall, this type of cancer includes a heterogeneous group of tumors with
different characteristics and behaviors. This makes the management and treatment of
LABC very challenging. Despite surgeons’ best efforts to remove locoregional
dissemination of the tumor, a high rate of locoregional and systemic failure has been seen
[7], [8]. Therefore, other different treatment strategies have been used for LABC over the
past several decades. The results of these treatments showed that multi-modality treatment
approaches (surgery, chemotherapy, radiotherapy, hormonal and targeted therapy) can
increase 5-year survival rate [9]–[11]. This type of cancer constitutes 10% to 20% of all
diagnosed breast cancer cases [12].
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1.1.2

Breast Cancer Screening, Detection, and Diagnosis

Early detection of breast cancer offers more treatment options and a higher chance of
survival. Breast cancer patients who are diagnosed early have a survival rate higher than
97 percent in the first five years following diagnosis [13], [14]. Therefore, detecting breast
abnormalities as early as possible is crucial for improvement of treatment outcome and
increasing survival rate.
Breast cancer screening is usually done via physical examinations and screening
mammography. In case of dense breasts, ultrasound (US) or magnetic resonance imaging
(MRI) may be used for screening. Breast cancer screening is suggested to be done on
people who are at risk of getting cancer but have no symptoms. Ontario Breast Screening
Program (OBSP) recommends that most women in age 50 to 74 be screened every 2 years
with mammography. For women in age 30 to 69, those who are known to have gene
mutation, are a first-degree relative of someone with a gene mutation, have a personal or
family history of breast or ovarian cancer, have had radiation therapy to the chest before
age 30 and at least 8 years ago are also recommended to be referred to the high risk OBSP
for further screening. Signs and symptoms of breast cancer include but are not limited to
discovering a lump in the breast, swelling or asymmetry of the breast, changes in the nipple,
erythema or ulceration in the skin, and axillary mass [15]. Up to 50% of women with breast
complaints, however, do not present with any physical signs of breast pathology [16]. In
case a suspicious lump is observed in screening, other imaging modalities may be used to
characterize it for detecting breast cancer . The most common modalities used for breast
cancer detection are diagnostic mammography if the breast is not too dense, US, and MRI.
Although these modalities can potentially indicate whether a lesion is highly suspicious for
malignancy, the gold standard approach to diagnose a malignant tumor is biopsy. Biopsy
is also done to characterize the breast cancer in terms of grade, molecular features/subtypes,
etc. for treatment planning. The result of all these diagnostic methods is described using a
standard approach known as BI-RADS (Breast Imaging Reporting and Data System),
which divides the results into six categories that are summarized in Table 1-1 [17], [18].
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Table 1-1: BI-RADS categories description [17], [18]
BI-RADS

Assessment

Management/recommendation

Category
0

Incomplete evaluation

1

Negative examination

2

Benign

3

Probably benign (non-palpable

Further imaging required

Short-interval follow-up

and circumscribed mass on a
baseline mammogram)
4

Suspicious abnormality:

Biopsy

4A: low probability of
malignancy (2%-10%)
4B: intermediate probability of
malignancy (10% to 50%)
4C: high probability of
malignancy (50% to 95%)
5

High probability of malignancy

Biopsy

(>95%)
6

1.1.2.1

Pathology proven malignancy

Treatment ongoing

Physical and Clinical Breast Exam

Breast examination includes inspection, palpation, and lymph node exam. During
inspection, shape, size, and symmetry characteristics of the breasts are recorded. The
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clinician also records any evidence of edema, erythema or ulceration of skin or the nipple.
The breast is then carefully and gently palpated. During palpation, the type of the tumor
(malignant or benign) can sometimes be determined based on some features of the
identified lesions. For example, most of benign lesions have very regular borders, whereas
cancerous lesions tend to be irregular in shape [19]. Also, a very stiff lesion is most likely
malignant, while benign lesions show more deformability and rubbery behavior [20]–[23].
Although these characteristics can better be identified through more advanced detection
methods such as mammography or ultrasound, they can be beneficial for early detection or
self-examination.

1.1.2.2

Mammography

Mammography involves acquiring X-ray images of the breast with low radiation doses.
This imaging modality can potentially detect both cancerous (malignant) and noncancerous (benign) tumors in the breast. Mammograms, which are images obtained using
this modality, can be helpful in finding small lumps in the breast that cannot be sensed by
hand during physical examination. However, they are known to be insufficient for early
diagnosis of breast cancer in women who have a higher risk of cancer in their family or
have a Breast Cancer (BRCA) gene mutation. Breast cancer can be detected at an early
stage by annual screening mammography, which monitors changes in the breast over time
[14]. Subsequently, diagnostic mammography is used as a complementary modality for
more accurate diagnosis. While effective for screening, mammogram interpretation is one
of the most technically challenging areas of radiology, especially in dense breasts. This
stems from that the X-ray attenuation coefficient of breast cancers and fibroglandular
tissues are similar. For this reason, clinicians look for regions with microcalcification and
shape irregularity that are usually signs of malignancy [24]. This makes it complex for the
radiologist to identify the cancerous areas. It has been observed that women with dense
breasts are more likely to develop breast cancer [25]–[27] while about half of breast cancers
in women with dense breasts are missed by mammograms [28], [29]. Therefore, it is
important for women with dense breasts to be screened by supplemental imaging
techniques such as ultrasound or MRI which are better at distinguishing fibroglandular
tissue and cancerous tissue.

6

1.1.2.3

Breast Ultrasound

Ultrasound imaging of the breast was first described in 1951 [30]. For the diagnosis and
management of breast abnormalities, ultrasound can be a useful adjuvant to mammography
[31]. A brightness mode (B-mode) ultrasound image is a cross-sectional image that depicts
the body’s tissues and organ borders. It is made up of echoes created by ultrasonic waves
reflecting at tissue boundaries and scattering from other small structures within tissues. The
term B-mode refers to the relationship between the brightness of the image at each place
and the strength or amplitude of the echo. B-mode images can provide information on the
shape and internal structure of lesions from various planes with great resolution in both
fatty and dense breasts. Furthermore, other novel technologies associated with ultrasound
has distinguished it from other imaging techniques. These technologies include ultrasound
elastography, contrast-enhanced ultrasound, three-dimensional ultrasound, and automatic
breast ultrasound. Among these technologies, ultrasound elastography is the focus of this
thesis and will be further discussed in Section 1.2.2 of this chapter.

1.1.2.4

Breast Magnetic Resonance Imaging (MRI)

MRI scans the distribution and magnetic properties of hydrogen atoms within human tissue
by using repetitive radiofrequency pulses in conjunction with precise spatial modulation of
a high magnetic field. With sensitivity ranging between 81% and 100% and specificity of
around 97%, it is known to have the highest accuracy for breast cancer detection compared
to other imaging modalities [32], [33]. Although ultrasound does not have any
supplemental value and information when MRI is used, it still outperforms MRI in being
cost-effectiveness and accessible, especially for women at lower risk.

1.1.2.5

Biopsy

If an area is identified as suspicious, a breast biopsy may be recommended. This is when
the assessment of breast cancer is assigned to BI-RADS 4 or 5. During breast biopsy, a
sample of breast tissue is removed for histopathology to confirm a malignancy and
determine the receptor status, molecular features, grade, and extent of the cancer.
Specifically, sentinel node biopsy can be used to see if cancer has progressed beyond the
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primary tumor location and into the lymphatic system. Fine-needle aspiration biopsy
(FNAB), which involved aspirating a small amount of tissue with a very thin needle, is
frequently used to confirm the diagnosis before a treatment is planned. Core needle biopsy
(CNB) is another type of biopsy which uses a larger needle for sampling the suspicious
areas. To accurately localize the suspicious area, the radiologist often utilizes other imaging
techniques such as ultrasound, MRI, or positron emission tomography (PET) as a guidance
for biopsy [34]–[38]. In some rare cases a surgical biopsy is required in which the breast
mass is surgically removed [39]. Although both FNAB and CNB have shown high
sensitivity (87% and 74%, respectively) and specificity (98% and 96%, respectively) in
cancer diagnosis [40], it is an invasive method and carries potential risks and side effects.
Nevertheless, it is the gold standard method to confirm that a lesion is malignant and is
required for treatment planning.

1.1.3

Breast Cancer Treatment

The treatment of breast cancer mostly depends on the subtype and stage of the cancer [41].
It also depends on age, general health, menopausal status, and genetic factors. TNM staging
system is used for most types of cancer. This system uses letters and numbers to describe
the tumor (T), lymph nodes (N), and whether or not the cancer has spread or metastasized
(M) [42]. Additionally, for some cancer types, other factors such as grade, biomarker, and
tumor genetics can be included in the staging of the cancer. Generally, for most of the
cancers, severity is characterized through a number (stage 0 to IV), with 0 being cancer in
situ, and IV being advanced or metastatic cancer.
Stage of the breast cancer as well as the tumor’s type are important for planning out its
treatment and management. Surgery, radiation therapy, chemotherapy, hormonal therapy,
targeted therapy, and immunotherapy are among treatment options for breast cancer. For
example, for early-stage invasive breast cancer or DCIS, surgery is recommended to
remove the tumor before it grows further, while for LABC which is characterized by larger
tumors, chemotherapy, radiotherapy, or hormonal therapy is recommended before the
surgery. This is called neoadjuvant therapy. This method of treatment makes the surgery
feasible because the tumor shrinks as a result of preoperative therapy. Another advantage
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of neoadjuvant therapy is potentially paving the way to a less invasive of lumpectomy
instead of mastectomy. Furthermore, in case there is any microscopic distant disease, it
will be treated early on, hence potentially preventing cancer recurrence.
The effectiveness of therapy on cancer cells is measured in terms of “response”. There
were various efforts in defining standardized response assessment criteria. World Health
Organization (WHO) criteria was the first large scale published criteria [43]. This criterion
described how to measure the lesion in detail. The size of the lesion was calculated as twodimensional measure with multiplication of longest diameter by its perpendicular one [43].
Response Evaluation Criteria in Solid Tumors (RECIST) was later introduced [44]. In this
criterion, the response rate was measured using unidimensional measurement of the tumor
as opposed to the bidimensional measurement in WHO criteria [44]. In addition, one of the
most important indicators of response is tumor histopathological change (based on residual
tumor cellularity) after neoadjuvant chemotherapy (NAC) [45], [46]. In some cases, tumor
shrinkage is not evident on standard imaging despite a histopathological response. Hence,
some studies [47], [48] have applied a modified response grading system that is based on
RECIST [44] and histopathological criteria [45]. It has been shown that there is a
significant correlation between the patient’s response to NAC and treatment outcome,
which leads to improved survival rate [49]–[52]. However, less than 30% of patients show
complete response to standard chemotherapy while about 30% to 40% of the patients are
complete non-responders [53]–[58]. Techniques used for breast cancer diagnosis can
potentially be used to monitor and assess the patient’s response with variable degrees of
effectiveness. Predicting patients’ response accurately and as early as possible after NAC
initiation may allow clinicians to make treatment adjustments. More details about different
techniques in this context will be provided in Section 1.2.1 of this chapter and Chapter 3.

1.2 Theory
This thesis is founded on several background topics. In this section, an overview of these
topics is provided.
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1.2.1

Elastography

Elastography is a novel non-invasive imaging technique that involves generating images
of tissue mechanical properties (elastograms). This technique involves measurement of
tissue deformation using specialized imaging modalities while an external mechanical
force is applied to the tissue. While other imaging modalities such as MRI have been used
for measuring tissue deformation, ultrasound elastography (USE) has emerged in clinic
because of its wide availability and relatively low cost. USE was first introduced and
described in the 1990s [59] but has been further developed in recent years. Currently
available UE techniques in the clinic can generally be classified into two groups of quasistatic and shear wave imaging. Other elastography techniques such as linear elastography
and non-linear elastography (hyper elastography) have been also investigated to obtain
more accurate elastograms that can potentially be used in more sensitive diagnostic
applications.
To generate elastograms, tissue elasticity needs to be measured. In an entirely elastic
material, elasticity can be described by Hooke’s law as shown in Equation (1-1) [60]. In
this equation, 𝜎 and 𝜀 are the stress and strain tensors, respectively and 𝐶 is the Christoffel
rank-four tensor consisting of 21 independent elastic constants [61]–[63].
𝜎 = 𝐶𝜀

(1-1)

Depending on the method of deformation, three main types of elastic moduli: Young’s
modulus (E), shear modulus (G), and bulk modulus (K) can be considered. The magnitude
of elastic modulus directly relates to the stiffness. The greater the elastic modulus the lower
the material’s tendency to deform, hence, the stiffer the material. In the following, different
types of elastography methods in which different elastic moduli are measured will be
further discussed in detail.

1.2.1.1

Ultrasound Shear Wave Elastography

In Shear Wave Elastography (SWE), a quantitative measurement of tissue stiffness is
estimated using the propagation velocity of shear waves inside the tissue. This is done by
generating shear waves using high-intensity pulses from the ultrasound transducer and
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propagating them into the tissue perpendicular to the ultrasound beam. The shear wave
speed (𝐶𝑠 ) can then be related to the shear modulus (G) using Equation (1-2) in which 𝜌 is
the material’s density.
𝐺

𝐶𝑠 = √𝜌

(1-2)

Young’s modulus (E) can also be measured in this technique using the relationship between
E and G which is as follows [64]:
𝐸 = 2(𝜈 + 1)𝐺

(1-3)

In the equation above, 𝜈 is the Poisson’s ratio which is usually approximated as 0.5 in soft
tissues. The reason for this approximation will be discussed in section 1.2.3.1. To
summarize, in SWE, an acoustic radiation force is induced into the tissue, leading to a shear
wave traveling through the tissue. Ultrasound imaging can then be used to see how fast this
wave travels through breast tissue, leading to an estimation for the stiffness of the tissue
and creating elasticity images [65].

1.2.1.2

Ultrasound Strain Elastography

In strain imaging, the normal strain as a result of an applied normal stress to the tissue is
measured. The measured strain can be imaged and used for assessment of tissue stiffness.
The normal stress is applied to the tissue via quasi-static stimulation of the tissue with an
ultrasound transducer while the RF data is being acquired. Using two RF data frames
corresponding to two compression states, the tissue displacement can be estimated [66]–
[69]. The tissue strain image is then calculated by spatially differentiating the displacement
fields. Assuming all tissue experiences uniform stress distribution, a region with higher
stiffness experiences less strain (deformation) than softer surrounding regions. This
information can be used for detecting a hard lesion within the tissue. While strain imaging
mostly relies on the derivative of the displacement which is in the same direction as the
external load, i.e., axial displacement, the displacement perpendicular to the direction of
external load or the lateral displacement field can also be useful in reconstructing more
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accurate elastograms for the purpose of linear elastography. More on this type of
elastography will be discussed in Section 1.2.1.3.
Several methods exist to estimate axial and lateral displacements using US radiofrequency
(RF) data, however, the influence of noise on displacement estimation remains a problem,
hence encouraging the development of noise reduction techniques necessary for image
reconstruction. Current efforts for noise reduction are based on US signal processing or
dedicated offline algorithms. On the US side, [70] and [71] introduced non-axial
oscillations/modulations in their respective imaging point spread functions, and [72] where
angular compounding is used to improve lateral displacements. Offline, algorithms focus
on time delay estimation (TDE) [67], [73]–[80]. TDE methods can be categorized into
regularized optimization-based, and window-based approaches. More details on these
methods will be discussed in Chapter 2. While the current motion tracking methods can
produce reasonably accurate axial displacement maps, the accuracy of their lateral
displacements are generally low. The reason is that lateral resolution is usually not as good
as axial resolution; because while axial resolution is limited by the ultrasound system and
transducer frequency, the limiting factor for lateral resolution is the beam width. At their
core, the motion-tracking techniques rely on regularization through imposing tissue
continuity and various field smoothness criteria. Utilizing tissue mechanics constraints
such as incompressibility, compatibility and tissue 3D deformation models have not been
rigorously investigated for formulating more effective regularization to find more accurate
2D displacement fields. In Chapter 2 of this thesis, a tissue mechanics-based algorithm will
be introduced that uses an initial estimation of axial and lateral displacements generated
from any motion-tracking method before using tissue mechanics principles as constraints
to further refine the axial and lateral displacement fields. The initial estimation of
displacement field in this work is obtained from a previously developed technique called
Global Ultrasound Elastography (GLUE) [74]. Furthermore, the results of this method will
be compared to one of the current state-of-the-art motion tracking methods called Secondorder Ultrasound Elastography (SOUL) [81]. Below, an overview of each of these
techniques will be given.
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1.2.1.2.1

Global Ultrasound Elastography (GLUE)

Global Ultrasound Elastography (GLUE) [74] is a regularized optimization-based
approach that utilizes two consecutive frames of RF data, one before the deformation of
the tissue, and one after that, to calculate the corresponding axial and lateral displacement
fields. In this method, the cost function incorporates similarity of echo amplitudes and
displacement continuity. In the first step of this method, dynamic programming (DP) is
used to calculate an initial integer displacement estimate. After that, DP estimates are
refined by minimizing a cost function that incorporates first-order displacement continuity
of the whole field. The novelty of this method is that it globally calculates TDE of all the
RF data simultaneously. Although, this simultaneous estimation allows a significant
improvement in the quality of both axial and lateral displacement, it only uses first-order
continuity in the cost function, thus strain continuity is not considered. Furthermore, there
is no evidence that the displacements generated using this technique follow tissue
mechanics principles reasonably accurately. Therefore, further investigation is needed to
develop techniques capable of generating more accurate displacement fields.

1.2.1.2.2

Second-order Ultrasound Elastography (SOUL)

Second-order Ultrasound Elastography (SOUL) [81] is another regularized optimizationbased technique that, similar to GLUE, starts with obtaining an initial estimate of
displacements using DP. However, the cost function for SOUL incorporates both firstorder and second-order regularization terms. With this change in the cost function, the
applied constraint represents the mechanics of tissue deformation more accurately. This
method can potentially result in more accurate displacement and strain fields, however, the
focus of that is the deformation data in the axial direction while estimation of the lateral
displacement field still has room for improvements.

1.2.1.3

Linear Elastography

While strain imaging has been shown to be useful for some clinical applications [68], [69],
[82], uniform stress distribution is an unrealistic assumption as tissue heterogeneity and
irregular loading on the organ’s surface lead to a non-uniform stress distribution.
Therefore, its accuracy in mapping tissue stiffness is limited. As such, more advanced
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techniques have been developed to image more reliable measures of tissue stiffness (e.g.,
Young’s modulus) using the measured displacement field. Several studies have
investigated different methods for estimating non-uniform distribution of stress which
allow the mechanical properties (stiffness) of the tissue to be measured [83]–[86].
Commonly, this is done via tissue mechanical simulation formulated from well-established
physical laws and provide equations that relate the biomechanical properties (shear
modulus, Poisson’s ratio, anisotropy, viscosity, non-linearity, and poroelasticity) to the
measured mechanical response. Having infinitesimal deformations, linear elastic behavior
for soft tissues is a valid assumption. In this case, the strain and stress tensor can be related
as shown in Equation (1-1). It is difficult to solve these equations on irregular and complex
geometries; therefore, numerical methods such as finite-element method (FEM) are used
to solve for elastic constants and determine the distribution of stiffness throughout the
tissue. As mentioned in the previous section, accurate reconstruction of a tissue’s relative
Young’s modulus (YM) image requires accurate tissue displacement, and strain data in
both axial and lateral direction. Therefore, improving the accuracy of these fields can have
a significant impact on the quality of the reconstructed elastograms.

1.2.1.4

Non-linear Elastography

The stress-strain relationship in soft tissues can only be assumed as linear within a small
range of deformation. For higher range of deformation or strain, soft tissue exhibits
intrinsic or geometric non-linearity. Intrinsic non-linearity is related to the physiological
components of the tissue while geometric non-linearity is defined as the change in stiffness
due to load redistribution corresponding to significant change in geometry [87]. As such,
most investigations and available data in the literature is based on applying small
deformation (strain less than 10%) to the soft tissue to be able to use the linear assumption
for strain imaging and modulus reconstruction. However, tissue non-linear behavior is
known to be useful for representing the tissue mechanical properties more accurately [88],
[89]. Nonlinear elastography aims at reconstruction of tissue hyperelastic parameters. This
can be done using iterative data inversion techniques.
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1.2.2
1.2.2.1

Mechanics Principles
Incompressibility Condition

An incompressible material is a material that preserves its volume when it undergoes
deformation. Since for a mechanical body, the divergence of the displacement vector
relates to the change in the volume, an equivalent condition for a material to be
incompressible is that the divergence of the displacement field is zero. This can be written
as Equation (1-4) in cartesian coordinates.
𝛻 ∙ 𝑈(𝑥, 𝑦, 𝑧) = 𝜕𝑢𝑥 /𝜕𝑥 + 𝜕𝑢𝑦 /𝜕𝑦 + 𝜕𝑢𝑧 /𝜕𝑧 = 0

(1-4)

For such material, the Poisson’s ratio which is a measure of Poisson effect is usually
approximated at ~0.5. Poisson effect is the tendency of a material to expand in directions
that are perpendicular to its compression direction. Fluids such as water are known to be
incompressible, thus, soft tissue which mostly consists of water can be approximated as a
nearly-incompressible material.

1.2.2.2

Compatibility Condition

A compatible material is a body that deforms without creating any gaps or overlaps.
Consequently, compatibility conditions are mathematical conditions that indicate whether
or not a certain deformation will result in a compatible state for the material. Such
deformation (or strain) is called a compatible strain tensor field which ascertains that the
material stays together after the deformation and the material’s displacement field is singlevalued and continuous. The 2-D compatibility equation (Equation (1-5)) shows the
relationship between the strains in a two-dimensional case for a compatible material.
𝜕2 𝜀𝑥𝑥
𝜕𝑦 2

1.2.2.3

+

𝜕2 𝜀𝑦𝑦
𝜕𝑥 2

𝜕2 𝜀𝑥𝑦

= 2 𝜕𝑥𝜕𝑦

(1-5)

Boussinesq Stress Distribution

In 1885, Boussinesq introduced a solution for determining the distribution of the stress in
a homogeneous and isotropic solid that can be modeled as semi-infinite mediun [90]. A
homogeneous solid is the one that consists of only one material, or the mechanical
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properties remain the same throughout the solid. The solid is considered to be isotropic if
its mechanical properties do not depend on the direction of loading. Finally, a semi-infinite
model has a single plane surface and extends to infinity in all directions. The Boussinesq
stress equations are calculated as a result of a point load applied to the surface. Stresses in
x, y, and z directions can be calculated using Equations (1-6), (1-7), and (1-8). In these
equations, (𝑥0 , 𝑦0 , 𝑧0 ) and (𝑥, 𝑦, 𝑧) are the coordinates of points T and P shown in Figure
Figure 1-1, respectively, while r is the Euclidean distance between them.

Figure 1-1. A schematic of a semi-infinite medium under a point load

𝜎𝑥𝑥

𝑃 3(𝑧0 − 𝑧)(𝑥0 − 𝑥)2
=
{
2𝜋
𝑟5

(1-6)

(𝑥0 − 𝑥)2 − (𝑦0 − 𝑦)2
− (1 − 2𝜈) [ 2
𝑟(𝑟 − (𝑧0 − 𝑧)2 )(𝑟 + (𝑧0 − 𝑧))
(𝑦0 − 𝑦)2 (𝑧0 − 𝑧)
− 3 2
]}
𝑟 (𝑟 − (𝑧0 − 𝑧)2 )
𝜎𝑦𝑦 =

𝑃 3(𝑧0 − 𝑧)(𝑦0 − 𝑦)2
{
2𝜋
𝑟5
− (1 − 2𝜈) [
−

(1-7)

(𝑦0 − 𝑦)2 − (𝑥0 − 𝑥)2
𝑟(𝑟 2 − (𝑧0 − 𝑧)2 )(𝑟 + (𝑧0 − 𝑧))

(𝑥0 − 𝑥)2 (𝑧0 − 𝑧)
]}
𝑟 3 (𝑟 2 − (𝑧0 − 𝑧)2 )
𝜎𝑧𝑧 =

3𝑃 (𝑧0 − 𝑧)3
2𝜋
𝑟5

(1-8)
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Furthermore, it is noteworthy that in these equations it is assumed that the solid is
weightless, unstressed, and obeys Hooke’s law. The solution developed by Boussinesq
takes advantage of zero displacement, strain, and stress boundary conditions at the
boundaries of the semi-infinite medium.

1.3 Literature Review
As mentioned earlier in this chapter, evaluating patient’s response is important specially
for LABC patients who are prescribed with multi-modality treatments. Current methods
for this evaluation involve either conventional (standard) methods such as monitoring
tumor size changes, and other novel investigational methods such as functional, metabolic,
or molecular changes. Monitoring tumor size changes can be done using physical
examination or standard anatomical imaging such as mammography, B-mode ultrasound
imaging, or MRI. The major problem with these conventional methods is that such changes
may take several months to become detectable. Therefore, they cannot be efficiently used
for early detection of patients’ response. In contrast, functional and molecular changes
occur long before morphological changes. Functional imaging modalities that have been
investigated for evaluating patients’ response include Dynamic Contrast Enhanced (DCE)
MRI, PET imaging, molecular breast imaging, and elastography. In this section, we will
review these imaging techniques and their performance in response evaluation.

1.3.1

Dynamic Contrast Enhanced (DCE) MRI

DCE-MRI can be used to assess multiple and quantifiable parameters related to tissue
perfusion and microvascular status. It is done by first acquiring images without contrast
enhancement, and then acquiring images over time during and after injection of a
paramagnetic contrast agent (CA) into the vascular system [91]. Consequently, DCE-MRI
examines the vascular environment over various timepoints, and the fluctuating signal can
be described using quantitative enhanced kinetic characteristics. Semi-quantitative
enhancement kinetic features, such as initial peak enhancement and the presence of delayed
phase washout are used to improve specificity for identifying malignancy [92].
In the evaluation of response to NAC, DCE-MRI tends to be more effective than
mammography or ultrasound. In a study of 24 patients, DCE-MRI was performed before
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and on average 19 days after the first NAC treatment cycle [93]. The parameters used in
this study were relative signal intensity (RSI) and area under the curve (AUC) which were
calculated from the DCE-curves. RSI was calculated by dividing the mean signal intensity
of images after CA injection to the mean signal intensity in the pre-contrast images. AUC
was calculated by numerally integrating the signal enhancement curves in each image
voxel [93]. This study concluded that DCE-MRI has the potential to predict 5-year survival
in patients with LABC with an area under the receiver operating characteristic (ROC) curve
(AUC) of 0.77 [93]. Furthermore, changes in tumor vascularization can be assessed after
one cycle of NAC [94]. In a study conducted in 2013, 21 patients with LABC underwent
high temporal resolution 3T DCE-MRI before and after one cycle of NAC to determine if
semi-quantitative analysis of high temporal resolution DCE-MRI can predict the response
to NAC in patients with LABC [94]. The assessed parameters for this purpose included
lesion size, radiologist’s subjective assessment of lesion enhancement, and percentages of
voxels within the lesion demonstrating progressive, plateau, or washout kinetics. If the
signal intensity of a voxel increases gradually and in a linear way this is called
‘progressive’; if it stays around the same value over time, this is commonly called as a
‘plateau’, and in case the signal fades gradually, it is referred to as a ‘washout’. The results
were promising and demonstrated that while parameters such as lesion size cannot predict
patients’ response after one cycle of NAC, change in percentage of voxels demonstrating
washout kinetics could discriminate responder and non-responder patients [94].
A more recent paper, studied 38 LABC patients who received NAC for 1-3 months while
their ultrasound, mammography and MRI data were compared to histopathology results
[95]. Type of response was determined with respect to the “Response Evaluation Criteria
in Solid Tumors (RECIST) 1.1” [96]. The correlation between the response type of all three
imaging modalities and histopathology response were assessed and compared. It was
shown that this correlation was very weak in mammography or ultrasound, whereas with
DCE-MR, it was possible to evaluate the treatment response accurately in 84.2% of the
patients 1-3 months after NAC [95]. In the same year, another study in the same area was
conducted to assess the potential of texture analysis applied to DCE-MRI for predicting
clinical and pathological response to NAC in patients with LABC. With a dataset including
58 LABC patients undergoing NAC, they presented promising results in the use of texture
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analysis of DCR-MR images for the use of NAC response prediction in LABC patients
[97]. Studying 35 patients diagnosed with stage II/III of breast cancer, quantitative,
multiregional analysis of DCE-MRI was used to predict pathological response of breast
cancer to NAC. The parameter for predicting pathological response was the change in
texture features in different subregions of tumor. According to their results, they concluded
that the heterogeneity of the tumor subregions on DCE-MRI can predict pathological
response to NAC in breast cancer [98]. In another similar study, DCE-MRI was acquired
in 14 patients at baseline, after two cycles, and after the end of chemotherapy sessions.
Several dynamic contrast parameters such as transfer constant (diffusion of contrast media
from the vascular space to the tumor interstitium which is a measure of vascular
permeability), rate constant (the period that takes for the contrast agent to diffuse back into
the vasculature), the extracellular extravascular space, initial area under the time signal
curve (IAUC), apparent diffusion coefficient (ADC), and enhancement curve were
generated for the purpose of comparison between responders and non-responders. In this
study, IAUC and ADC were found to be useful in distinguishing responders from nonresponders after two or three cycles of chemotherapy [99].
It is noteworthy that although it has shown promise for evaluating breast cancer response
to NAC, DCE-MRI is relatively expensive, not widely accessible, and involves injection
of exogenous contrast agents for each assessment during treatment.

1.3.2

Positron Emission Tomography (PET)

Several studies have shown that nuclear medicine imaging, such as positron emission
tomography (PET), can be used to assess tumor response to treatment by detecting early
changes in tumor metabolism. 18F-flurodeoxyglucose (FDG), a glucose analogue, can be a
measure of tissue glucose metabolism which is often high in high-grade cancers and low
in low-grade tumors. To evaluate its efficacy in response detection, FDG-PET/CT was
performed on 40 patients with invasive ductal carcinoma at baseline and after two cycles
of NAC [100]. Pathologic response of these patients was evaluated after surgery using
Residual Cancer Burden (RCB) index [101]. Their results suggest that FDG-PET/CT can
discriminate NAC responder and non-responder patients after two courses of NAC with
68% sensitivity and 75% specificity [100]. An older study with 14 patients has also proved
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the usefulness of 3'-[F-18]Fluoro-3'-deoxythymidine (FLT)-PET in monitoring breast
cancer response to chemotherapy after two weeks from the first course of chemotherapy
where a significantly reduced FLT uptake was observed compared to pretreatment scans
[102]. Similar to DCE-MRI, this imaging modality is very costly, has limited accessibility
and need the injection of radionuclide contrast agents. This limits the frequency of scanning
patients for response evaluation throughout the chemotherapy course.

1.3.3

Quantitative Ultrasound (QUS)

QUS procedures, unlike medical ultrasonography, are used to measure quantitative
variables in order to characterize tissue properties rather than to acquire anatomical images
from internal organs [103]. QUS assessment of breast tumor response to chemotherapy was
conducted in a study involving 58 LABC patients prior to NAC treatment and at weeks 1,
4, and 8 of their treatment, and before surgery. The parameters assessed in this study
include midband fit (MBF), spectral slope (SS), spectral intercept (SI), spacing among
scatterers (SAS), attenuation coefficient estimate (ACE), average scatterer diameter
(ASD), and average acoustic concentration (AAC) of the tumor region. The results
indicated that a hybrid QUS biomarker (MBF, SS, and SAS) was able to detect the response
of LABC patients to NAC after 4 weeks of therapy with relatively high sensitivity and
specificity (around 80%) [104]. An older study from the same group also suggested that
QUS can be used for detecting tumors from normal breast tissue and also differentiating
tumor grades [105]. Later, this finding was consolidated by a larger dataset (116 patients)
in which surrounding tissue and tumor lesions were classified using a combination of
Nakagami distribution1 shape parameter, entropy, and texture parameters with sensitivity
of 93% and specificity of 88% [106]. Using a dataset of 100 patients with breast cancer,
QUS biomarkers that quantify spatial heterogeneities in size, concentration and spacing of
acoustic scatterers were used and showed success in predicting treatment responses of
patients [107]. In a recent study, different computational algorithms were tested on QUS
and textural analysis data of 100 LABC patients to best determine tumor responses after
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the start of NAC. Among linear discriminant, k-nearest-neighbor, and a nonlinear support
vector machine classifier, the latter performed the best in differentiating responders from
non-responders with accuracies of 78%, 90%, and 92% at weeks 1, 4, and 8 after NAC
initiation [108]. The same classifier with another dataset of 59 LABC patients showed the
highest accuracy of 81% at weeks 1 and 4 with area under curve (AUC) values of 0.87 each
in classifying patients based on their response [109]. The underlying principle of these
studies is that QUS biomarkers which are related to the linear regression of the tissue power
spectrum are directly related to the tissue microstructure, thus, can characterize the
abnormalities of different tissues e.g. breast [110]. Moreover, QUS has shown to be
effective in detecting and quantifying tumor cell death in vivo, in response to various
treatments such as photodynamic therapy, radiation therapy, chemotherapy, and antivascular therapy [111]–[114]. To conclude, QUS shows highly accurate results, and its
hardware system is inexpensive, smaller than that of other similar imaging systems, and do
not require the use of ionizing radiation or contrast agent injection.

1.3.4

Breast Ultrasound Elastography

Several studies have shown that there is a significant correlation between chemotherapy
response and tumor softening [115], [116]. In other words, given that chemotherapy causes
apoptosis and other forms of cell death in tumors, ECM composition is expected to be
considerably altered during effective treatment [117]–[121]. Tissue stiffness reduction
could be one signature of such changes. A study involving 15 patients with LABC showed
that relative tumor stiffness can be a differentiating factor between NAC responders and
non-responders after 4 weeks of treatment initiation [115]. The feasibility of strain imaging
and real time shear wave elastography (RT-SWE) to evaluate early tumor response to
chemotherapy was demonstrated in [122] using an animal model. Although most studies
reported tumor softening as a result of chemotherapy, this investigation showed that the
stiffness of tumor determined by UE increases in response to chemotherapy at a very early
stage i.e., at the day after the last dosing [122]. In another study, mass characteristic
frequency, shear wave elastography, and mass size were used for assessing early prediction
of tumor response to NAC in a dataset of 62 patients with biopsy-proven invasive breast
cancer. The SWE was acquired at three time points: before, mid-course, and after NAC.
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An SWE parameter which can be explained as the inverse of the maximum shear wave
propagation time in a breast mass showed a significant difference between responders and
non-responders in the mid-course of NAC treatment [116]. Ultrasound strain elastography
has also shown to be useful with high sensitivity (84%) and specificity (85%) in another
study for predicting response to NAC as early as two weeks after the start of treatment
[123]. With low cost and readily availability, ultrasound elastography is known to be highly
efficient in the clinical setting. Further improving the accuracy of response prediction using
this imaging modality, by addressing its issues and enhancement of its underlying
algorithms of displacement data estimation and image reconstruction, can potentially make
this modality highly competitive compared to other methods in predicting NAC response
in LABC patients.

1.4 Objectives
The overarching objective of this study is to develop novel methods for ultrasound
elastography to improve its accuracy and reliability in clinical settings. Once developed,
the methods were applied to a clinical dataset acquired through an observational study on
LABC patients who underwent NAC. Results from this study was used to assess the
efficacy of our enhanced ultrasound elastography technique in evaluating LABC patient
response soon after the start of NAC.
The focus of our work is on quasi-static ultrasound elastography where the tissue is
externally excited by pressing the ultrasound probe against the breast. The first specific
aim of research included in this thesis is to develop a novel technique which uses
mathematical constraints derived from fundamental tissue mechanics principles to
regularize displacement and strain fields obtained using existing methods. The second
specific aim focuses on evaluating this development for early determination of LABC
patients’ response to NAC. In this aim the technique developed in the previous specific
aim is used within a full inversion elastography framework to obtain Young’s modulus
images of a clinical dataset of a group of LABC patients undergoing NAC. The Young’s
modulus ratio of tumor to the healthy tissue was then calculated to assess the correlation
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between change in the tumor Young’s modulus throughout the NAC and the final response
of the patients.

1.5 Thesis Outline
The thesis objectives defined above has been pursued in the following chapters followed
by a final chapter where the thesis summary and future work are discussed. The outline of
each chapter is explained below.

1.5.1

Chapter 2

In ultrasound elastography, tissue displacements are mainly measured based on RF data
correlation while the physics governing tissue deformation is hardly considered. Previous
studies have shown that soft tissue can be modelled as incompressible material.
Furthermore, like other continua, soft tissue deforms without developing any
gaps/overlaps, hence mathematically constraining the relationship between different
components of the displacement field. Furthermore, to account for 3D tissue
incompressibility, a novel method was developed and used for estimating out-of-plane
strain data based on axial and lateral strain data which can be derived from 2D US RF data.
In this chapter, we present a novel technique developed based on the above mentioned
principles for refining displacement and strain fields which were previously measured
using conventional methods. The technique was validated using an in silico breast
ultrasound model, four tissue-mimicking phantoms, and clinical breast ultrasound
elastography. The results show significant improvement in accuracy, SNR and CNR of
both displacement and strain fields.

1.5.2

Chapter 3

In this chapter, first, a technique was developed for the purpose of reconstructing Young’s
modulus as a measure of tissue stiffness. The technique follows a full-inversion finite
element framework to which the enhanced displacements are fed as input data while the
boundary conditions of the US FOV was also derived from these displacements. Next, this
more accurate full-inversion-based ultrasound elastography was adapted to evaluate its
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performance in predicting the response of a group of 25 LABC patients to NAC. The
technique was utilized using data acquired before and at weeks 1, 2, and 4 after the start of
NAC. The Young’s modulus ratio of tumor to the surrounding tissue was calculated at
different scans and compared to the baseline for each patient. Patients' response to NAC
was determined many months later using standard clinical and histopathological criteria.
Results of the enhanced elastography technique proposed in this study demonstrate a high
potential for chemotherapy response monitoring in LABC patients.

1.5.3

Chapter 4

The information presented in previous chapters is summarized in this chapter. The
dissertation was closed by proposing possible directions for this study in the future.

References
[1]

“Breast cancer statistics | Canadian Cancer Society.” https://cancer.ca/en/cancerinformation/cancer-types/breast/statistics (accessed Jan. 17, 2022).

[2]

L. Smith et al., “Members of the Canadian Cancer Statistics Advisory Committee
Analytic leads,” 2019.

[3]

Y. S. Khan and H. Sajjad, “Anatomy, Thorax, Mammary Gland,” StatPearls, Jul.
2021, [Online]. Available: https://www.ncbi.nlm.nih.gov/books/NBK547666/.

[4]

J. Makki, “Diversity of Breast Carcinoma: Histological Subtypes and Clinical
Relevance,” Clin. Med. Insights. Pathol., vol. 8, no. 1, p. 23, 2015, doi:
10.4137/CPATH.S31563.

[5]

D. J. A. Adamson and A. M. Thompson, “Locally advanced breast cancer,” Breast
Surg., pp. 219–229, Jan. 2014, doi: 10.1016/B978-0-7020-4959-0.00013-8.

[6]

O. M. Fayanju, P. B. Garvey, M. S. Karuturi, K. K. Hunt, and I. Bedrosian, “Surgical
Procedures for Advanced Local and Regional Malignancies of the Breast,” Breast
Compr. Manag. Benign Malig. Dis., p. 778–801.e4, Jan. 2018, doi: 10.1016/B9780-323-35955-9.00059-3.

[7]

P. K. Garg and G. Prakash, “Current definition of locally advanced breast cancer,”
Curr. Oncol., vol. 22, no. 5, p. e409, Oct. 2015, doi: 10.3747/CO.22.2697.

[8]

D. Simos, M. Clemons, O. M. Ginsburg, and C. Jacobs, “Definition and
consequences of locally advanced breast cancer,” Curr. Opin. Support. Palliat.
Care, vol. 8, no. 1, pp. 33–38, 2014, doi: 10.1097/SPC.0000000000000020.

24

[9]

M. C. Lee and L. A. Newman, “Management of patients with locally advanced
breast cancer,” Surg. Clin. North Am., vol. 87, no. 2, pp. 379–398, Apr. 2007, doi:
10.1016/J.SUC.2007.01.012.

[10]

P. Valagussa et al., “T3b-T4 breast cancer: factors affecting results in combined
modality treatments,” Clin. Exp. Metastasis, vol. 1, no. 2, pp. 191–202, Apr. 1983,
doi: 10.1007/BF00121498.

[11]

W. G. Cance et al., “Long-term outcome of neoadjuvant therapy for locally
advanced breast carcinoma: effective clinical downstaging allows breast
preservation and predicts outstanding local control and survival,” Ann. Surg., vol.
236, no. 3, pp. 295–303, Sep. 2002, doi: 10.1097/01.SLA.0000027526.67560.64.

[12]

B. Fowble, A. Bevan, M. Alvarado, and M. Melisko, “Cancer of the Breast,” in
Leibel and Phillips Textbook of Radiation Oncology, Elsevier, 2010, pp. 1215–1323.

[13]

A. Migowski, “[Early detection of breast cancer and the interpretation of results of
survival studies],” Cien. Saude Colet., vol. 20, no. 4, pp. 1309–1310, 2015, doi:
10.1590/1413-81232015204.17772014.

[14]

L. Wang, “Early Diagnosis of Breast Cancer,” Sensors (Basel)., vol. 17, no. 7, Jul.
2017, doi: 10.3390/S17071572.

[15]

M. M. Koo, C. von Wagner, G. A. Abel, S. McPhail, G. P. Rubin, and G.
Lyratzopoulos, “Typical and atypical presenting symptoms of breast cancer and
their associations with diagnostic intervals: Evidence from a national audit of cancer
diagnosis,” Cancer Epidemiol., vol. 48, p. 140, Jun. 2017, doi:
10.1016/J.CANEP.2017.04.010.

[16]

D. S. Smink, “Schwartz’s Principles of Surgery, 10th Edition,” Ann. Surg., vol. 261,
no. 5, p. 1026, May 2015, doi: 10.1097/SLA.0000000000001107.

[17]

W. A. Berg, C. Campassi, P. Langenberg, and M. J. Sexton, “Breast Imaging
Reporting and Data System,” Am. J. Roentgenol., vol. 174, no. 6, pp. 1769–1777,
Aug. 2021, doi: 10.2214/ajr.174.6.1741769.

[18]

D. A. Spak, J. S. Plaxco, L. Santiago, M. J. Dryden, and B. E. Dogan, “BI-RADS ®
fifth edition: A summary of changes,” Diagn. Interv. Imaging, vol. 98, no. 3, pp.
179–190, Mar. 2017, doi: 10.1016/J.DIII.2017.01.001.

[19]

L. I. Everson, “Mammographic Interpretation: A Practical Approach,”
https://doi.org/10.1148/radiology.185.3.864, vol. 185, no. 3, pp. 864–864, Dec.
1992, doi: 10.1148/RADIOLOGY.185.3.864.

[20]

J. Fenner, A. C. Stacer, F. Winterroth, T. D. Johnson, K. E. Luker, and G. D. Luker,
“Macroscopic Stiffness of Breast Tumors Predicts Metastasis,” Sci. Reports 2014
41, vol. 4, no. 1, pp. 1–8, Jul. 2014, doi: 10.1038/srep05512.

25

[21]

I. Acerbi et al., “Human breast cancer invasion and aggression correlates with ECM
stiffening and immune cell infiltration,” Integr. Biol. (United Kingdom), vol. 7, no.
10, pp. 1120–1134, Oct. 2015, doi: 10.1039/c5ib00040h.

[22]

J. H. Youk, E. J. Son, H. M. Gweon, H. Kim, Y. J. Park, and J. A. Kim, “Comparison
of strain and shear wave elastography for the differentiation of benign from
malignant breast lesions, combined with B-mode ultrasonography: qualitative and
quantitative assessments,” Ultrasound Med. Biol., vol. 40, no. 10, pp. 2336–2344,
2014, doi: 10.1016/J.ULTRASMEDBIO.2014.05.020.

[23]

J. Yoo et al., “Tumor stiffness measured by shear wave elastography correlates with
tumor hypoxia as well as histologic biomarkers in breast cancer,” Cancer Imaging,
vol. 20, no. 1, pp. 1–10, Dec. 2020, doi: 10.1186/S40644-020-00362-7/TABLES/4.

[24]

D. M. Ikeda and K. K. Miyake, “Breast imaging,” p. 465, Accessed: Jan. 28, 2022.
[Online].
Available:
https://books.google.com/books/about/Breast_Imaging_The_Requisites_E_Book.h
tml?id=DhgZDQAAQBAJ.

[25]

C. I. Lee, L. E. Chen, and J. G. Elmore, “Risk-Based Breast Cancer Screening:
Implications of Breast Density,” Med. Clin. North Am., vol. 101, no. 4, p. 725, Jul.
2017, doi: 10.1016/J.MCNA.2017.03.005.

[26]

K. Kerlikowske, D. L. Miglioretti, and C. M. Vachon, “Discussions of Dense
Breasts, Breast Cancer Risk, and Screening Choices in 2019,” JAMA, vol. 322, no.
1, p. 69, Jul. 2019, doi: 10.1001/JAMA.2019.6247.

[27]

S. M. Advani et al., “Association of Breast Density With Breast Cancer Risk Among
Women Aged 65 Years or Older by Age Group and Body Mass Index,” JAMA Netw.
Open, vol. 4, no. 8, pp. e2122810–e2122810, Aug. 2021, doi:
10.1001/JAMANETWORKOPEN.2021.22810.

[28]

T. M. Kolb, J. Lichy, and J. H. Newhouse, “Comparison of the performance of
screening mammography, physical examination, and breast US and evaluation of
factors that influence them: An analysis of 27,825 patient evaluations,” Radiology,
vol. 225, no. 1, pp. 165–175, Oct. 2002, doi: 10.1148/RADIOL.2251011667.

[29]

W. A. Berg et al., “Detection of Breast Cancer With Addition of Annual Screening
Ultrasound or a Single Screening MRI to Mammography in Women With Elevated
Breast Cancer Risk,” JAMA, vol. 307, no. 13, pp. 1394–1404, Apr. 2012, doi:
10.1001/JAMA.2012.388.

[30]

J. J. Wild and D. Neal, “USE OF HIGH-FREQUENCY ULTRASONIC WAVES
FOR DETECTING CHANGES OF TEXTURE IN LIVING TISSUES,” Lancet,
vol. 257, no. 6656, pp. 655–657, Mar. 1951, doi: 10.1016/S0140-6736(51)92403-8.

[31]

A. Evans et al., “Breast ultrasound: recommendations for information to women and
referring physicians by the European Society of Breast Imaging,” Insights Imaging,

26

vol. 9, no. 4, p. 449, Aug. 2018, doi: 10.1007/S13244-018-0636-Z.
[32]

R. M. Mann, N. Cho, and L. Moy, “Breast MRI: State of the Art,” Radiology, vol.
292, no. 3, pp. 520–536, 2019, doi: 10.1148/RADIOL.2019182947.

[33]

R. M. Mann, C. K. Kuhl, and L. Moy, “Contrast-enhanced MRI for breast cancer
screening,” J. Magn. Reson. Imaging, vol. 50, no. 2, pp. 377–390, Aug. 2019, doi:
10.1002/JMRI.26654.

[34]

A. A. Bhatt, D. H. Whaley, and C. U. Lee, “Ultrasound-Guided Breast Biopsies:
Basic and New Techniques,” J. Ultrasound Med., vol. 40, no. 7, pp. 1427–1443, Jul.
2021, doi: 10.1002/JUM.15517.

[35]

V. S. Klimberg and A. Rivere, “Ultrasound image-guided core biopsy of the breast,”
Chinese Clin. Oncol., vol. 5, no. 3, 2016, doi: 10.21037/CCO.2016.04.05.

[36]

N. S. Winkler, “Ultrasound Guided Core Breast Biopsies,” Tech. Vasc. Interv.
Radiol., vol. 24, no. 3, Sep. 2021, doi: 10.1016/J.TVIR.2021.100776.

[37]

A. J. Lilly et al., “MRI-guided core needle biopsy of the breast: Radiologypathology correlation and impact on clinical management,” Ann. Diagn. Pathol.,
vol. 48, Oct. 2020, doi: 10.1016/J.ANNDIAGPATH.2020.151563.

[38]

J. E. Kalinyak et al., “PET-guided breast biopsy,” Breast J., vol. 17, no. 2, pp. 143–
151, Mar. 2011, doi: 10.1111/J.1524-4741.2010.01044.X.

[39]

D. Ha, V. Dialani, T. S. Menta, W. Keefe, E. Luanow, and P. J. Slanetz, “Mucocelelike lesions in the breast diagnosed with percutaneous biopsy: is surgical excision
necessary?,” AJR. Am. J. Roentgenol., vol. 204, no. 1, pp. 204–210, Jan. 2015, doi:
10.2214/AJR.13.11988.

[40]

M. Wang, X. He, Y. Chang, G. Sun, and L. Thabane, “A sensitivity and specificity
comparison of fine needle aspiration cytology and core needle biopsy in evaluation
of suspicious breast lesions: A systematic review and meta-analysis,” Breast, vol.
31, pp. 157–166, Feb. 2017, doi: 10.1016/J.BREAST.2016.11.009.

[41]

A. G. Waks and E. P. Winer, “Breast Cancer Treatment: A Review,” JAMA - J. Am.
Med. Assoc., vol. 321, no. 3, pp. 288–300, Jan. 2019, doi: 10.1001/jama.2018.19323.

[42]

S. Kalli, A. Semine, S. Cohen, S. P. Naber, S. S. Makim, and M. Bahl, “American
joint committee on cancer’s staging system for breast cancer, eighth edition: What
the radiologist needs to know,” Radiographics, vol. 38, no. 7, pp. 1921–1933, Nov.
2018,
doi:
10.1148/RG.2018180056/ASSET/IMAGES/LARGE/RG.2018180056.FIG14G.JP
EG.

[43]

A. Miller, B. Hoogstraten, M. Staquet, A. W.- cancer, and undefined 1981,
“Reporting results of cancer treatment,” Wiley Online Libr., Accessed: Mar. 14,

27

2022.
[Online].
Available:
https://acsjournals.onlinelibrary.wiley.com/doi/abs/10.1002/10970142(19810101)47:1%3C207::AID-CNCR2820470134%3E3.0.CO;2-6.
[44]

E. A. Eisenhauer et al., “New response evaluation criteria in solid tumours: Revised
RECIST guideline (version 1.1),” doi: 10.1016/j.ejca.2008.10.026.

[45]

K. N. Ogston et al., “A new histological grading system to assess response of breast
cancers to primary chemotherapy: prognostic significance and survival,” Breast,
vol. 12, no. 5, pp. 320–327, 2003, doi: 10.1016/S0960-9776(03)00106-1.

[46]

E. Hanafy, A. Al Jabri, G. Gadelkarim, A. Dasaq, F. Nazim, and M. Al Pakrah,
“Tumor histopathological response to neoadjuvant chemotherapy in childhood solid
malignancies: is it still impressive?,” J. Investig. Med., vol. 66, no. 2, pp. 289–297,
Feb. 2018, doi: 10.1136/JIM-2017-000531.

[47]

H. Moghadas-Dastjerdi, H. R. Sha-E-Tallat, L. Sannachi, A. Sadeghi-Naini, and G.
J. Czarnota, “A priori prediction of tumour response to neoadjuvant chemotherapy
in breast cancer patients using quantitative CT and machine learning,” Sci. Reports
2020 101, vol. 10, no. 1, pp. 1–11, Jul. 2020, doi: 10.1038/s41598-020-67823-8.

[48]

H. Tadayyon et al., “A priori prediction of breast tumour response to chemotherapy
using quantitative ultrasound imaging and artificial neural networks,” Oncotarget,
vol. 10, no. 39, pp. 3910–3923, 2019, doi: 10.18632/ONCOTARGET.26996.

[49]

B. Fisher et al., “Effect of preoperative chemotherapy on the outcome of women
with operable breast cancer,” J. Clin. Oncol., vol. 16, no. 8, pp. 2672–2685, 1998,
doi: 10.1200/JCO.1998.16.8.2672.

[50]

S. J. Cleator, A. Makris, S. E. Ashley, R. Lal, and T. J. Powles, “Good clinical
response of breast cancers to neoadjuvant chemoendocrine therapy is associated
with improved overall survival,” Ann. Oncol. Off. J. Eur. Soc. Med. Oncol., vol. 16,
no. 2, pp. 267–272, 2005, doi: 10.1093/ANNONC/MDI049.

[51]

A. Romero et al., “Correlation between response to neoadjuvant chemotherapy and
survival in locally advanced breast cancer patients,” Ann. Oncol., vol. 24, no. 3, pp.
655–661, 2013, doi: 10.1093/annonc/mds493.

[52]

L. M. Spring et al., “Pathologic Complete Response after Neoadjuvant
Chemotherapy and Impact on Breast Cancer Recurrence and Survival: A
Comprehensive Meta-analysis,” Clin. Cancer Res., vol. 26, no. 12, pp. 2838–2848,
Jun. 2020, doi: 10.1158/1078-0432.CCR-19-3492.

[53]

D. Sethi, R. Sen, S. Parshad, S. Khetarpal, M. Garg, and J. Sen, “Histopathologic
changes following neoadjuvant chemotherapy in locally advanced breast cancer,”
Indian J. Cancer, vol. 50, no. 1, pp. 58–64, 2013, doi: 10.4103/0019-509X.112301.

[54]

S. Chuthapisith, J. M. Eremin, M. El-Sheemy, and O. Eremin, “Neoadjuvant

28

chemotherapy in women with large and locally advanced breast cancer:
chemoresistance and prediction of response to drug therapy,” Surgeon, vol. 4, no. 4,
pp. 211–219, 2006, doi: 10.1016/S1479-666X(06)80062-4.
[55]

G. N. Hortobagyi, “Multidisciplinary management of advanced primary and
metastatic breast cancer,” Cancer, vol. 74, no. 1 S, pp. 416–423, 1994, doi:
10.1002/cncr.2820741329.

[56]

S. H. Giordano, “Update on locally advanced breast cancer,” Oncologist, vol. 8, no.
6, pp. 521–530, Dec. 2003, doi: 10.1634/THEONCOLOGIST.8-6-521.

[57]

W. Haque, V. Verma, S. Hatch, V. Suzanne Klimberg, E. Brian Butler, and B. S.
Teh, “Response rates and pathologic complete response by breast cancer molecular
subtype following neoadjuvant chemotherapy,” Breast Cancer Res. Treat., vol. 170,
no. 3, pp. 559–567, Aug. 2018, doi: 10.1007/S10549-018-4801-3.

[58]

T. Byrski et al., “Pathologic complete response rates in young women with BRCA1positive breast cancers after neoadjuvant chemotherapy,” J. Clin. Oncol., vol. 28,
no. 3, pp. 375–379, Jan. 2010, doi: 10.1200/JCO.2008.20.7019.

[59]

J. L. Gennisson, T. Deffieux, M. Fink, and M. Tanter, “Ultrasound elastography:
principles and techniques,” Diagn. Interv. Imaging, vol. 94, no. 5, pp. 487–495,
2013, doi: 10.1016/J.DIII.2013.01.022.

[60]

L. D. Landau and E. M. Lifshitz, Theory of elasticity, Volume 7 (Theoretical
Physics). Butterworth-Heinemann, 1986.

[61]

J. F. Greenleaf, M. Fatemi, and M. Insana, “Selected Methods for Imaging Elastic
Properties of Biological Tissues,” Annu. Rev. Biomed. Eng., vol. 5, no. 1, pp. 57–
78, Aug. 2003, doi: 10.1146/annurev.bioeng.5.040202.121623.

[62]

Fung, Biomechanics: Mechanical Properties of Living Tissues, Second Edition:
1993.

[63]

J. Ophir et al., “Elastography: Ultrasonic estimation and imaging of the elastic
properties of tissues,” Proc. Inst. Mech. Eng. Part H J. Eng. Med., vol. 213, no. 3,
pp. 203–233, Mar. 1999, doi: 10.1243/0954411991534933.

[64]

T. Shiina et al., “WFUMB guidelines and recommendations for clinical use of
ultrasound elastography: Part 1: basic principles and terminology,” Ultrasound Med.
Biol.,
vol.
41,
no.
5,
pp.
1126–1147,
May
2015,
doi:
10.1016/J.ULTRASMEDBIO.2015.03.009.

[65]

A. P. Sarvazyan, O. V. Rudenko, S. D. Swanson, J. B. Fowlkes, and S. Y.
Emelianov, “Shear wave elasticity imaging: a new ultrasonic technology of medical
diagnostics,” Ultrasound Med. Biol., vol. 24, no. 9, pp. 1419–1435, Dec. 1998, doi:
10.1016/S0301-5629(98)00110-0.

29

[66]

G. S. Gherlan, “Liver ultrasound elastography: More than staging the disease,”
World Journal of Hepatology, vol. 7, no. 12. Baishideng Publishing Group Co, pp.
1595–1600, 2015, doi: 10.4254/wjh.v7.i12.1595.

[67]

M. A. Lubinski, S. Y. Emelianov, and M. O’Donnell, “Speckle tracking methods for
ultrasonic elasticity imaging using short-time correlation,” IEEE Trans. Ultrason.
Ferroelectr. Freq. Control, vol. 46, no. 1, pp. 82–96, Jan. 1999, doi:
10.1109/58.741427.

[68]

A. R. Skovoroda, S. Y. Emelianov, M. A. Lubinski, A. P. Sarvazyan, and M.
O’Donnell, “Theoretical analysis and verification of ultrasound displacement and
strain imaging,” IEEE Trans. Ultrason. Ferroelectr. Freq. Control, vol. 41, no. 3,
pp. 302–313, May 1994, doi: 10.1109/58.285463.

[69]

T. Varghese, “Quasi-Static Ultrasound Elastography,” Ultrasound Clinics, vol. 4,
no. 3. NIH Public Access, pp. 323–338, Jul. 2009, doi: 10.1016/j.cult.2009.10.009.

[70]

J. A. Jensen and P. Munk, “A new method for estimation of velocity vectors,” IEEE
Trans. Ultrason. Ferroelectr. Freq. Control, vol. 45, no. 3, pp. 837–851, 1998, doi:
10.1109/58.677749.

[71]

M. E. Andcrson, “Multi-dimensional velocity estimation with ultrasound using
spatial quadrature,” IEEE Trans. Ultrason. Ferroelectr. Freq. Control, vol. 45, no.
3, pp. 852–861, 1998, doi: 10.1109/58.677757.

[72]

U. Techavipoo, Q. Chen, T. Varghese, and J. A. Zagzebski, “Estimation of
displacement vectors and strain tensors in elastography using angular
insonifications,” IEEE Trans. Med. Imaging, vol. 23, no. 12, pp. 1479–1489, Dec.
2004, doi: 10.1109/TMI.2004.835604.

[73]

H. Rivaz, E. M. Boctor, M. A. Choti, and G. D. Hager, “Real-time regularized
ultrasound elastography,” IEEE Trans. Med. Imaging, vol. 30, no. 4, pp. 928–945,
2011, doi: 10.1109/TMI.2010.2091966.

[74]

H. S. Hashemi and H. Rivaz, “Global Time-Delay Estimation in Ultrasound
Elastography,” IEEE Trans. Ultrason. Ferroelectr. Freq. Control, vol. 64, no. 10,
pp. 1625–1636, 2017, doi: 10.1109/TUFFC.2017.2717933.

[75]

M. Mirzaei, A. Asif, and H. Rivaz, “Combining Total Variation Regularization with
Window-Based Time Delay Estimation in Ultrasound Elastography,” IEEE Trans.
Med. Imaging, vol. 38, no. 12, pp. 2744–2754, Dec. 2019, doi:
10.1109/TMI.2019.2913194.

[76]

M. Ashikuzzaman, C. J. Gauthier, and H. Rivaz, “Global ultrasound elastography in
spatial and temporal domains,” IEEE Trans. Ultrason. Ferroelectr. Freq. Control,
vol. 66, no. 5, pp. 876–887, May 2019, doi: 10.1109/TUFFC.2019.2903311.

[77]

M. G. Kibria and H. Rivaz, “GLUENet: Ultrasound elastography using

30

convolutional neural network,” Lect. Notes Comput. Sci. (including Subser. Lect.
Notes Artif. Intell. Lect. Notes Bioinformatics), vol. 11042 LNCS, pp. 21–28, 2018,
doi: 10.1007/978-3-030-01045-4_3.
[78]

I. Céspedes, J. Ophir, and M. Insana, “Theoretical Bounds on Strain Estimation in
Elastography,” IEEE Trans. Ultrason. Ferroelectr. Freq. Control, vol. 42, no. 5, pp.
969–971, 1995, doi: 10.1109/58.464850.

[79]

W. F. Walker and G. E. Trahey, “A Fundamental Limit on Delay Estimation Using
Partially Correlated Speckle Signals,” IEEE Trans. Ultrason. Ferroelectr. Freq.
Control, vol. 42, no. 2, pp. 301–308, 1995, doi: 10.1109/58.365243.

[80]

Y. Zhu and T. J. Hall, “A modified block matching method for real-time freehand
strain imaging,” Ultrason. Imaging, vol. 24, no. 3, pp. 161–176, 2002, doi:
10.1177/016173460202400303.

[81]

A. M, S.-N. A, S. A, and R. H, “Combining First- and Second-Order Continuity
Constraints in Ultrasound Elastography,” IEEE Trans. Ultrason. Ferroelectr. Freq.
Control,
vol.
68,
no.
7,
pp.
2407–2418,
Jul.
2021,
doi:
10.1109/TUFFC.2021.3065884.

[82]

A. Sarvazyan, T. J. Hall, M. W. Urban, M. Fatemi, S. R. Aglyamov, and B. S. Garra,
“An Overview of Elastography-An Emerging Branch of Medical Imaging,” Curr.
Med. Imaging Rev., vol. 7, no. 4, pp. 255–282, Nov. 2011, doi:
10.2174/157340511798038684.

[83]

H. Karimi, A. Fenster, and A. Samani, “A novel fast full inversion based breast
ultrasound elastography technique,” Phys. Med. Biol., vol. 58, no. 7, pp. 2219–2233,
Apr. 2013, doi: 10.1088/0031-9155/58/7/2219.

[84]

D. T. Seidl, A. A. Oberai, and P. E. Barbone, “The Coupled Adjoint-State Equation
in forward and inverse linear elasticity: Incompressible plane stress,” Comput.
Methods Appl. Mech. Eng., vol. 357, Dec. 2019, doi: 10.1016/j.cma.2019.112588.

[85]

H. Mehrabian and A. Samani, “An iterative hyperelastic parameters reconstruction
for breast cancer assessment,” Med. Imaging 2008 Physiol. Funct. Struct. from Med.
Images, vol. 6916, no. March 2008, p. 69161C, 2008, doi: 10.1117/12.770971.

[86]

S. R. Mousavi, H. Rivaz, A. Sadeghi-Naini, G. J. Czarnota, and A. Samani, “Breast
Ultrasound Elastography Using Full Inversion-Based Elastic Modulus
Reconstruction,” IEEE Trans. Comput. Imaging, vol. 3, no. 4, pp. 774–782, 2017,
doi: 10.1109/tci.2017.2741422.

[87]

P. S. Wellman, E. P. Dalton, D. Krag, K. A. Kern, and R. D. Howe, “Tactile Imaging
of Breast Masses: First Clinical Report,” Arch. Surg., vol. 136, no. 2, pp. 204–208,
Feb. 2001, doi: 10.1001/ARCHSURG.136.2.204.

[88]

H. T. Liu, L. Z. Sun, G. Wang, and M. W. Vannier, “Analytic modeling of breast

31

elastography,” Med. Phys., vol. 30, no. 9, pp. 2340–2349, Sep. 2003, doi:
10.1118/1.1599953.
[89]

T. Hu and J. P. Desai, “Characterization of Soft-Tissue Material Properties: Large
Deformation Analysis,” Lect. Notes Comput. Sci. (including Subser. Lect. Notes
Artif. Intell. Lect. Notes Bioinformatics), vol. 3078, pp. 28–37, 2004, doi:
10.1007/978-3-540-25968-8_4.

[90]

J. (1842-1929). A. du texte Boussinesq, “Application des potentiels à l’étude de
l’équilibre et du mouvement des solides élastiques, principalement au calcul des
déformations et des pressions que produisent, dans les solides, des efforts
quelquonques exercés sur une petite partie de leur surface ou de leur intérieur :
mémoire suivi de notes étendues sur divers points de physique mathématique et
d’analyse / par J. Boussinesq,...,” 1885, Accessed: Mar. 08, 2021. [Online].
Available: https://gallica.bnf.fr/ark:/12148/bpt6k9651115r.

[91]

Y. Gordon et al., “Dynamic contrast-enhanced magnetic resonance imaging:
fundamentals and application to the evaluation of the peripheral perfusion,”
Cardiovasc. Diagn. Ther., vol. 4, no. 2, p. 147, 2014, doi: 10.3978/J.ISSN.22233652.2014.03.01.

[92]

J. Xiao et al., “Dynamic contrast-enhanced breast MRI features correlate with
invasive breast cancer angiogenesis,” npj Breast Cancer 2021 71, vol. 7, no. 1, pp.
1–9, Apr. 2021, doi: 10.1038/s41523-021-00247-3.

[93]

R. Johansen et al., “Predicting survival and early clinical response to primary
chemotherapy for patients with locally advanced breast cancer using DCE-MRI,” J.
Magn. Reson. Imaging, vol. 29, no. 6, pp. 1300–1307, Jun. 2009, doi:
10.1002/jmri.21778.

[94]

R. G. Abramson et al., “Early assessment of breast cancer response to neoadjuvant
chemotherapy by semi-quantitative analysis of high-temporal resolution DCE-MRI:
Preliminary results,” Magn. Reson. Imaging, vol. 31, no. 9, pp. 1457–1464, Nov.
2013, doi: 10.1016/j.mri.2013.07.002.

[95]

N. S. Gezer, O. Orbay, P. Balci, M. G. Durak, B. Demirkan, and S. Saydam,
“Evaluation of Neoadjuvant Chemotherapy Response with Dynamic Contrast
Enhanced Breast Magnetic Resonance Imaging in Locally Advanced Invasive
Breast Cancer,” J. Breast Heal., vol. 10, no. 2, pp. 111–118, May 2014, doi:
10.5152/TJBH.2014.2035.

[96]

E. A. Eisenhauer et al., “New response evaluation criteria in solid tumours: revised
RECIST guideline (version 1.1),” Eur. J. Cancer, vol. 45, no. 2, pp. 228–247, Jan.
2009, doi: 10.1016/J.EJCA.2008.10.026.

[97]

J. R. Teruel et al., “Dynamic contrast-enhanced MRI texture analysis for
pretreatment prediction of clinical and pathological response to neoadjuvant
chemotherapy in patients with locally advanced breast cancer,” NMR Biomed., vol.

32

27, no. 8, pp. 887–896, 2014, doi: 10.1002/NBM.3132.
[98]

J. Wu, G. Gong, Y. Cui, and R. Li, “Intratumor partitioning and texture analysis of
dynamic contrast-enhanced (DCE)-MRI identifies relevant tumor subregions to
predict pathological response of breast cancer to neoadjuvant chemotherapy,” J.
Magn. Reson. Imaging, vol. 44, no. 5, pp. 1107–1115, Nov. 2016, doi:
10.1002/jmri.25279.

[99]

A. Sharma, S. Sharma, S. Sood, R. K. Seam, M. Sharma, and V. Fotedar, “DCEMRI and parametric imaging in monitoring response to neoadjuvant chemotherapy
in breast carcinoma: a preliminary report,” Polish J. Radiol., vol. 83, p. e220, 2018,
doi: 10.5114/PJR.2018.76271.

[100] W. P. Andrade et al., “Can FDG-PET/CT predict early response to neoadjuvant
chemotherapy in breast cancer?,” Eur. J. Surg. Oncol., vol. 39, no. 12, pp. 1358–
1363, Dec. 2013, doi: 10.1016/j.ejso.2013.08.025.
[101] W. F. Symmans et al., “Measurement of residual breast cancer burden to predict
survival after neoadjuvant chemotherapy,” J. Clin. Oncol., vol. 25, no. 28, pp. 4414–
4422, Oct. 2007, doi: 10.1200/JCO.2007.10.6823.
[102] B. S. Pio et al., “Usefulness of 3’-[F-18]fluoro-3’-deoxythymidine with positron
emission tomography in predicting breast cancer response to therapy,” Mol. imaging
Biol., vol. 8, no. 1, pp. 36–42, Jan. 2006, doi: 10.1007/S11307-005-0029-9.
[103] R. Barkmann, “Quantitative ultrasound,” Grampp S. Radiol. Osteoporosis. Med.
Radiol. (Diagnostic Imaging), pp. 412–474, Apr. 2016, doi: 10.1007/978-3-54068604-0_11.
[104] H. Tadayyon et al., “Quantitative ultrasound assessment of breast tumor response to
chemotherapy using a multi-parameter approach,” Oncotarget, vol. 7, no. 29, pp.
45094–45111, 2016, doi: 10.18632/ONCOTARGET.8862.
[105] H. Tadayyon, A. Sadeghi-Naini, L. Wirtzfeld, F. C. Wright, and G. Czarnota,
“Quantitative ultrasound characterization of locally advanced breast cancer by
estimation of its scatterer properties,” Med. Phys., vol. 41, no. 1, p. 012903, Jan.
2014, doi: 10.1118/1.4852875.
[106] Z. Klimonda, P. Karwat, K. Dobruch-Sobczak, H. Piotrzkowska-Wróblewska, and
J. Litniewski, “Breast-lesions characterization using Quantitative Ultrasound
features of peritumoral tissue,” Sci. Rep., vol. 9, no. 1, pp. 1–9, Dec. 2019, doi:
10.1038/s41598-019-44376-z.
[107] A. Sadeghi-Naini et al., “Chemotherapy-Response Monitoring of Breast Cancer
Patients Using Quantitative Ultrasound-Based Intra-Tumour Heterogeneities,” Sci.
Rep., vol. 7, no. 1, Dec. 2017, doi: 10.1038/S41598-017-09678-0.
[108] L. Sannachi et al., “Breast Cancer Treatment Response Monitoring Using

33

Quantitative Ultrasound and Texture Analysis: Comparative Analysis of Analytical
Models,” Transl. Oncol., vol. 12, no. 10, pp. 1271–1281, Oct. 2019, doi:
10.1016/j.tranon.2019.06.004.
[109] K. Quiaoit et al., “Quantitative ultrasound radiomics for therapy response
monitoring in patients with locally advanced breast cancer: Multi-institutional study
results,” PLoS One, vol. 15, no. 7, p. e0236182, Jul. 2020, doi:
10.1371/journal.pone.0236182.
[110] F. L. Lizzi, M. Ostromogilsky, E. J. Feleppa, M. C. Rorke, and M. M. Yaremko,
“Relationship of ultrasonic spectral parameters to features of tissue microstructure,”
IEEE Trans. Ultrason. Ferroelectr. Freq. Control, vol. 34, no. 3, pp. 319–329, 1987,
doi: 10.1109/T-UFFC.1987.26950.
[111] A. Sadeghi-Naini et al., “Conventional frequency ultrasonic biomarkers of cancer
treatment response in vivo,” Transl. Oncol., vol. 6, no. 3, pp. 234–243, 2013, doi:
10.1593/TLO.12385.
[112] G. J. Czarnota et al., “Tumor radiation response enhancement by acoustical
stimulation of the vasculature,” Proc. Natl. Acad. Sci. U. S. A., vol. 109, no. 30, Jul.
2012, doi: 10.1073/PNAS.1200053109.
[113] R. M. Vlad, S. Brand, A. Giles, M. C. Kolios, and G. J. Czarnota, “Quantitative
ultrasound characterization of responses to radiotherapy in cancer mouse models,”
Clin. Cancer Res., vol. 15, no. 6, pp. 2067–2075, Mar. 2009, doi: 10.1158/10780432.CCR-08-1970.
[114] B. Banihashemi, R. Vlad, B. Debeljevic, A. Giles, M. C. Kolios, and G. J. Czarnota,
“Ultrasound imaging of apoptosis in tumor response: novel preclinical monitoring
of photodynamic therapy effects,” Cancer Res., vol. 68, no. 20, pp. 8590–8596, Oct.
2008, doi: 10.1158/0008-5472.CAN-08-0006.
[115] O. Falou et al., “Evaluation of neoadjuvant chemotherapy response in women with
locally advanced breast cancer using ultrasound elastography,” Transl. Oncol., vol.
6, no. 1, pp. 17–24, 2013, doi: 10.1593/tlo.12412.
[116] J. Gu et al., “Early assessment of shear wave elastography parameters foresees the
response to neoadjuvant chemotherapy in patients with invasive breast cancer,”
Breast Cancer Res., vol. 23, no. 1, pp. 1–13, Dec. 2021, doi: 10.1186/S13058-02101429-4/TABLES/3.
[117] M. K. Jena and J. Janjanam, “Role of extracellular matrix in breast cancer
development: a brief update,” F1000Research, vol. 7, 2018, doi:
10.12688/F1000RESEARCH.14133.2.
[118] C. Walker, E. Mojares, and A. Del Río Hernández, “Role of Extracellular Matrix in
Development and Cancer Progression,” Int. J. Mol. Sci., vol. 19, no. 10, 2018, doi:
10.3390/IJMS19103028.

34

[119] S. Xu et al., “The role of collagen in cancer: from bench to bedside,” J. Transl. Med.
2019 171, vol. 17, no. 1, pp. 1–22, Sep. 2019, doi: 10.1186/S12967-019-2058-1.
[120] J. Winkler, A. Abisoye-Ogunniyan, K. J. Metcalf, and Z. Werb, “Concepts of
extracellular matrix remodelling in tumour progression and metastasis,” Nat.
Commun. 2020 111, vol. 11, no. 1, pp. 1–19, Oct. 2020, doi: 10.1038/s41467-02018794-x.
[121] T. Armstrong et al., “Type I collagen promotes the malignant phenotype of
pancreatic ductal adenocarcinoma,” Clin. Cancer Res., vol. 10, no. 21, pp. 7427–
7437, Nov. 2004, doi: 10.1158/1078-0432.CCR-03-0825.
[122] J. W. Wang et al., “Ultrasound elastography as an imaging biomarker for detection
of early tumor response to chemotherapy in a murine breast cancer model: a
feasibility study,” Br. J. Radiol., vol. 91, no. 1085, 2018, doi:
10.1259/BJR.20170698.
[123] J. Fernandes et al., “Monitoring Breast Cancer Response to Neoadjuvant
Chemotherapy Using Ultrasound Strain Elastography,” Transl. Oncol., vol. 12, no.
9, p. 1177, Sep. 2019, doi: 10.1016/J.TRANON.2019.05.004.

35

Chapter 2

2

A Novel Tissue Mechanics-based Method for Improving
Tissue Displacement and Strain Estimation in Breast
Ultrasound Elastography

A version of this chapter has been submitted as a journal paper for publication in
Medical Physics.

2.1 Introduction
Breast cancer is the second most diagnosed cancer in women, estimated to affect 1 in 8
Canadian women during their lifetime. It was estimated that in 2021, 27,700 women will
die from breast cancer in the United States [1]. Vital to successful treatment of the patient,
early detection achieved through regular breast cancer screening has shown to reduce
mortality by 25% in the first 10 years where treating stage 1 cancer has the highest survival
rate [2], [3]. The most common medical imaging technique used for breast cancer screening
is X-ray mammography. However, due to ionizing radiation, the frequency of testing using
this method is constrained, potentially delaying critically needed early diagnosis. Another
concern of this screening method is that it is influenced by breast density and hormone
replacement therapy, hence impacting its sensitivity for breast cancer detection, especially
with young women with dense breasts where reported sensitivities are as low as ~60% [4],
[5].
When X-ray mammograms are inconclusive, B-mode ultrasound (US) imaging and
magnetic resonance imaging (MRI) are used. While the B-mode US is widely available
and inexpensive, image quality is a limiting factor that impacts its sensitivity and
specificity. Being highly sensitive, MRI is very effective for abnormality detection.
However, its high cost and limited availability have ruled out its routine utility for early
detection. As such, different investigations have been actively conducted to develop
affordable imaging techniques with high sensitivity and specificity. One promising option
towards this goal is elastography [6]–[8] where maps of tissue stiffness are generated and
visualized. In the context of breast cancer, this is motivated by the fact that many types of
cancer, including ductal carcinoma which is the most common type of breast cancer, are
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associated with biological changes that lead to tissue stiffening [9]–[12]. As such, breast
tissue stiffening may be evaluated for breast cancer detection. Among elastography
techniques, quasi-static ultrasound elastography (USE) has been shown to be effective in
stiffness imaging for a wide range of oncology applications, including breast, prostate and
liver cancers [13]–[18]. Benefits of USE include involvement of the non-invasive low-cost
ultrasound (US) imaging, being free of harmful radiation, fast data acquisition and image
reconstruction.
In quasi-static elastography, a low-frequency external loading is applied for tissue
mechanical stimulation by pressing the US probe against the breast. US radiofrequency
(RF) data is then acquired during tissue compression whereby an RF data frame is collected
at each time instant of compression. Using two RF data frames corresponding to two
compression states, the tissue displacement data can be estimated [6], [19]–[21]. The tissue
strain image calculated by differentiating the displacement field is considered the simplest
form of elastography which is often integrated into US systems for real-time imaging [6].
Assuming tissue stress uniformity, strain images generated through this method can be
regarded as an approximation to tissue stiffness maps (e.g., hard lesions appear as low
strain areas).
While strain imaging has been shown to be useful for some clinical applications [22], due
to the weakness of the stress uniformity assumption, its accuracy is limited. As such, more
advanced techniques have been developed to image more reliable measures of tissue
stiffness (e.g. Young’s modulus) using the measured displacement field [22].
In both strain imaging and Young’s modulus imaging, the primary determining factor of
accuracy is the accuracy of the tissue displacement data consisting of axial and lateral
displacement fields. Young’s modulus image reconstruction involves an ill-posed inverse
problem. This ill-posedness issue can be mitigated if reliable estimates of both axial and
lateral displacement components are available. Several methods exist to estimate axial and
lateral displacements using US RF data; however, the low signal-to-noise (SNR) ratio and
the 2D nature of conventional US imaging have limited the accuracy of estimated
displacements, especially the lateral displacement component. This has encouraged efforts
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toward the development of more robust methods for displacement estimation. Estimation
of tissue displacement and strain distribution in USE can be considered as an optical flow
(OF) problem which involves minimization of an energy equation imposing both echo
amplitude conservation and displacement smoothness constraints [23]–[27]. More
recently, deep learning methods were proposed for displacement and strain estimation
which proved promising while further improvement is necessary [28]–[30]. Other
algorithms mostly focus on time delay estimation (TDE) methods [19], [30]–[37] where
the TDE can be obtained for small windows of RF data. TDE involves a search which can
be performed in either 1D or 2D corresponding to search in the axial direction only or in
both lateral and axial directions, respectively [36], [37]. While they generally provide
accurate estimate in the axial direction, these approaches are too sensitive to signal
decorrelation which often occurs in clinical breast imaging. Another effective approach
followed to develop a robust method against signal decorrelation involves optimization
constrained by regularization which imposes smoothness of tissue deformation [31], [32].
In this approach, the displacement is estimated along a single RF-line, leading to
displacement discontinuity between adjacent RF-lines and low accuracy of the lateral
displacement field [31]. To avoid this, the displacement estimation can be performed
simultaneously for all RF lines [32]. This method leads to excessively smooth displacement
field, hence blurry strain images. To address this issue, a window-based term in
conjunction with first or second order derivative-based regularization were employed in
other relevant works considered the state-of-the-art methods in this field [33], [38]. A
number of other studies have investigated utilizing more than two RF frames to estimate
the displacement fields [34], [39]–[42]. A downside of these methods is lack of systematic
way to determine the weighting coefficients. In another category of displacement
estimation methods, known as quality-guided motion tracking [43]–[47], the displacement
is first estimated for the points in high correlation local region. Subsequently, a
displacement continuity constraint is used to estimate the displacements of the points in
low correlation local regions based on the previously estimated displacements of points in
high correlation regions. In addition to being computationally more efficient, this qualityguided motion tracking method has shown to operate well in regions with poorly correlated
RF data and also geometrically irregular regions [45].
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While existing tissue motion tracking methods can produce reasonably accurate axial
displacement maps, the accuracy of their lateral displacements are generally low. At their
core, these techniques rely on regularization through imposing tissue continuity and
various field smoothness criteria. Utilizing tissue mechanics constraints such as
incompressibility, compatibility and tissue 3D deformation models have not been as
rigorously investigated for formulating more effective regularization to find more accurate
2D displacement fields. As an attempt to incorporate such constraints towards improved
displacement estimation, approximate tissue mechanics-based relations founded on the
stress uniformity assumption were derived and incorporated in an algorithm that uses three
US RF frames [39]. Efforts have been also made to utilize the partial differential equations
governing the linear elastic deformation in soft tissue. This includes a method proposed to
estimate tissue lateral displacement field using measured axial displacement field based on
tissue incompressibility condition [48]. The method assumes plane strain conditions and it
was shown that the estimated lateral displacement field was more accurate and had higher
SNR compared with a field estimated using traditional speckle tracking. The method was
then extended to account for large deformation conditions under plane strain assumption
[49]. Also, through assuming plane strain conditions, a nearly incompressible constraint
was used as a regularization term in a pixel-wise model-based algorithm to estimate all
components of vascular strain (axial, lateral and shear) with a high spatial resolution [50].
Incompressibility constraint has also been used in other methods by incorporating
confidence weights for different tissue regions, momentum conservation equation in
conjunction with a robust H_∞ filter [51], [52]. More recently, a mathematical framework
was developed to improve an estimate of tissue axial and lateral displacement fields while
the shear modulus was also reconstructed simultaneously [53]. The framework assumes
plane stress conditions and tissue incompressibility while it does not require traction or
displacement boundary conditions.
In this chapter, we introduce a novel algorithm that uses an estimation of out-of-plane strain
to improve the in-plane tissue displacement and strain fields, especially their lateral
component. Unlike previous studies, the proposed method neither assumes plane strain nor
plane stress conditions and instead is founded on tissue mechanics principles of
incompressibility and compatibility. To enforce tissue incompressibility, in contrast to

39

using the plane strain or plane stress assumptions, we use Boussinesq’s equation to
analytically estimate the out-of-plane strain.

2.2 Materials and Methods
2.2.1

Overview of Strain Refinement Algorithm (STREAL)

The proposed algorithm requires an initial estimate of the displacements to be processed
before an improved estimate is generated. To obtain an initial estimate of the tissue axial
and lateral displacement fields, we process a suitable pair of acquired RF data frames using
publicly available computer programs developed based on the Global Ultrasound
Elastography (GLUE) method [31], [32]. These fields are then refined step-by-step by first
smoothing and then enforcing the fundamental tissue mechanics conditions of
incompressibility and compatibility. Smoothing and incompressibility condition
enforcement leads to improved displacement fields estimate while the compatibility
condition enforcement applies further improvement, leading to the final strain fields. A
flowchart of STREAL is illustrated in Figure 2-1.

Figure 2-1. Strain Refinement Algorithm (STREAL) flowchart
1)

Step 1: Second Order Derivative Based Regularization

To further regularize the initial displacement data where first order derivative-based
regularization is already applied, we use regularization which seeks a new estimate of the
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displacement field where the 2D Laplacian of the displacement components throughout the
field of view (FOV) is minimized. The 2D-Laplacian of the displacement field U is
expressed mathematically by:
𝛻𝑈(𝑥, 𝑦) = 𝜕 2 𝑈(𝑥, 𝑦)/𝜕𝑥 2 + 𝜕 2 𝑈(𝑥, 𝑦)/𝜕𝑦 2

(2-1)

This operator can be expressed in a matrix form by applying the finite difference
approximation of this operator to each point in the FOV, leading to the following matrix
form:
𝛻𝑈(𝑥, 𝑦) = 𝐿𝑈

(2-2)

where L is a matrix with entries of the finite difference coefficients and U is a 1D vector
containing both axial and lateral displacement fields. The entries of L are arranged such
that each row of Equation (2-2) yields the finite difference approximation of the Laplacian
operator at each point. The solution sought in this step is one that minimizes the Laplacian
while it matches the input displacements obtained from the previous step (𝑈𝑚 ) as much as
possible. This leads to the following minimization equation of Tikhonov regularization:
𝑀𝑖𝑛. (‖𝑈 − 𝑈𝑚 ‖2 + 𝜆2 ‖𝐿𝑈‖2 )

(2-3)

where ‖. ‖ represents the Eulerian norm and 𝜆2 represents a positive weight coefficient.
This minimization leads to the following least squares solution:
𝑈𝑛𝑒𝑤 = (𝐼 + 𝜆2 𝐿𝑇 𝐿) 𝑈𝑚

(2-4)

The regularization weight coefficient, 𝜆, determines the level of smoothness. This
coefficient is found automatically using the L-curve technique [54] where a solution U is
found for various 𝜆 values before ‖𝐿𝑈‖ is plotted against ‖𝑈 − 𝑈𝑚 ‖. Typically, this plot
resembles an L-curve, and the knee point of this curve corresponds to a 𝜆 value that is
considered optimal as it corresponds to the best trade-off between smoothness and original
data matching (Figure 2-2).
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Figure 2-2. The L-curve plot and its knee point which corresponds to an optimal 𝝀 value.
2)

Step 2: Tissue Incompressibility Enforcement

Tissue incompressibility is expressed mathematically by setting the divergence of the
displacement field in 3D to zero as follows:
𝛻 ∙ 𝑈(𝑥, 𝑦, 𝑧) = 𝜕𝑢𝑥 /𝜕𝑥 + 𝜕𝑢𝑦 /𝜕𝑦 + 𝜕𝑢𝑧 /𝜕𝑧 = 0

(2-5)

where in the context of US image coordinate system, 𝑥, 𝑦, and 𝑧 correspond to lateral,
axial, and out-of-plane directions, respectively as shown in Figure 2-2. Since conventional
US data does not provide information on out-of-plane displacements, assumptions such as
plane-strain and plane-stress have been used as discussed in the introduction. Assuming
plane-strain conditions, in which the out-of-plane strain is zero, the incompressibility
condition leads to the following equation:
𝜕𝑢𝑥 /𝜕𝑥 + 𝜕𝑢𝑦 /𝜕𝑦 = 0

(2-6)

The plane strain assumption considered in previous works, however, is not valid in breast
USE as it requires constant section geometry and loading of tissue along the z direction
[53]. As an alternative, other works assumed plane stress condition which requires very
thin tissue geometry undergoing in-plane loading only [48]. Neither of these requirements
are met in the context of breast USE. To assess the deviation of the plane strain and plane
stress assumptions from actual 3D situations, we conducted an in silico experiment of
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breast USE using ABAQUS FE solver (ABAQUS 2019, Dassault Systèmes Simulia Corp.,
Johnston, RI, USA). In this experiment a typical breast geometry derived from a breast MR
image was converted into a homogeneous hyperelastic breast FE model with hyperelastic
parameters assigned based on values reported in the literature [55]. This model was
virtually compressed by an US probe to simulate a typical USE procedure. The simulation
was conducted using 3D geometry and loading as the ground truth model while 2D plane
strain and plane stress conditions were also simulated to evaluate their deviation from the
“true” 3D model. For this evaluation, the ratio of the mean difference between the “true”
and 2D displacement fields to the mean value of the “true” field was calculated for both
axial and lateral displacement components. For the plane strain case, this led to values of
0.84 and 4.73 for the axial and lateral components, respectively. For the plane stress case,
the ratio values were 0.79 and 2.87, respectively. While this experiment, which involves a
single breast, is not rigorous, the obtained large values, especially the ones pertaining to
the plane strain assumption are sufficient to motivate developing a modified
incompressibility equation that can be used more reliably in breast USE.
In this study, we estimate the out-of-plane strain considering the breast undergoing a US
probe loading as a semi-infinite medium. A semi-infinite solid is an idealized body with a
single planar surface that extends in all directions to infinity. In 1885, Boussinesq
developed equations for determining stresses at any point (T) in an elastic, semi-infinite,
homogeneous, and isotropic solid medium as a result of a surface concentrated point load
(P) [56]. Considering the dimensions of ultrasound probe with respect to the dimensions
of breast in supine position, breast can be considered as a semi-infinite medium, thus, axial
and out-of-plane stresses can be calculated using Equations (2-7), (2-8), and (2-9) which
represent Boussinesq stress equations. As shown in Figure 2-3, in these equations,
(𝑥0 , 𝑦0 , 𝑧0 ) and (𝑥, 𝑦, 𝑧) are the coordinates of points T and P, respectively, while r is the
Euclidean distance between them. It is noteworthy that while the calculated stresses using
Boussinesq stress equations are local due to the assumption of concentrated point load, in
our case, the stresses are calculated based on an integration over the surface of ultrasound
probe, hence they do not remain local.
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Figure 2-3: Boussinesq’s model - a schematic of a semi-infinite medium under a point
load
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Assuming a uniformly distributed loading applied by the US probe on the surface of the
breast, axial and out-of-plane stresses at every point in the US FOV (Figure 2-4a) can be
calculated by integration of Equations (2-7), (2-8), and (2-9) on the surface of the applied
load. Thus, using Hooke’s law, the axial and out-of-plane strains can be calculated as given
in Equation (2-10).
𝜆

𝜆+𝜇

𝜀𝑦𝑦
2𝜇(3𝜆+2𝜇)
[𝜀 ] = [
𝜆
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(2-10)

Where 𝜇 and 𝜆 are Lame’ parameters.
In this work, we assume that the breast is linear elastic with a Young’s modulus, E, value
of 3kPa [57] and Poisson’s ratio of 0.495. The Poisson’s ratio value is consistent with the
high-water content composition of most soft tissue, including breast tissue. While some
intra- and inter-patient variability is expected, our simulation indicates that modest
variability does not impact estimated displacement fields significantly. The Lame’
parameters can be calculated using the following equation.
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𝐸𝜈

𝐸

𝜆 = (1+𝜈)(1−2𝜈) , 𝜇 = 2(1+𝜈)
Thereafter, the ratio (𝑘 =

𝜕𝑢𝑧
𝜕𝑧

/

𝜕𝑢𝑦
𝜕𝑦

=

𝜀𝑧𝑧
𝜀𝑦𝑦

(2-11)

) of the out-of-plane to axial strain can be

calculated, leading to the following modified incompressibility equation.
𝜕𝑢𝑥 /𝜕𝑥 + (𝑘 + 1)𝜕𝑢𝑦 /𝜕𝑦 = 0

(2-12)

The finite difference form of Boussinesq’s equations can be rewritten in a matrix form as
follows:
𝐶𝑈 = 0

(2-13)

Here, 𝑈 contains the lateral and axial displacements only, and C is a matrix containing
coefficients of the finite difference approximation of Equation (2-12) which depends on 𝑘
values calculated for each point within the FOV. 𝐶 is dependent on the dimensions of the
FOV only and can be calculated once and stored for use in efficient estimation of improved
displacements. Having this equation in addition to the displacement fields obtained from
the previous step (𝑈𝑚 ), i.e., 𝐼𝑈 = 𝑈𝑚 , we can form the following linear system of equations
and solve it to obtain an improved estimate of 𝑈.
0
𝐶
[ ] 𝑈 = [ ] → 𝐴𝑈 = 𝑏
𝑈𝑚
𝐼

(2-14)

1

In this work, we seek 𝑈 ∈ ℝ which minimizes 2 𝑈 𝑇 𝐴𝑇 𝐴𝑈 − (𝐴𝑇 𝑏)𝑇 𝑈. As such, Equation
(2-14) can be solved efficiently using the Polak-Ribiere conjugate gradient method [57].
Since the initial estimate of axial displacements are known to be more accurate than their
lateral counterparts, we also employed weighted least-squares optimization [58] when
solving Equation (2-14). For this purpose, 𝑊 was considered as the weight diagonal matrix
where 𝑤𝑖,𝑖 represents the importance of 𝑖 𝑡ℎ row in Equation (2-14). This equation is an
augmented system consisting of three different sets of equations. With 𝑚 × 𝑛 data grid, the
first part has 𝑁1 = (𝑚 − 1) × (𝑛 − 1) rows which is related to incompressibility, the
second and third parts each have 𝑁2 = 𝑚 × 𝑛 rows pertaining to the measured axial and
lateral displacements, respectively. For each part, we assign a single weight denoted by
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𝑤𝑖𝑛𝑐 , 𝑤𝑙𝑎𝑡 and 𝑤𝑎𝑥 corresponding to the incompressibility, axial displacements, and lateral
displacements, respectively, leading to the weight matrix given in Equation (2-15). With
this alternative, we form 𝑊𝐴𝑈 = 𝑊𝑏 and use the Polak-Ribiere conjugate gradient method
to solve it, leading to a further refined displacement field.
𝑤𝑖𝑛𝑐
⋱
𝑤𝑖𝑛𝑐

0
𝑤𝑙𝑎𝑡

𝑊=

⋱

(2-15)
𝑤𝑙𝑎𝑡

0

𝑤𝑎𝑥
⋱

[

𝑤𝑎𝑥 ]

In this work, we used the three different weight sets presented in Table 2-1. The rationale
for choosing these weight factors is based on the reliability of each set of data. In these
sets, the ratio of 𝑤𝑎𝑥 to 𝑤𝑙𝑎𝑡 was set to 10 based on a typical SNR ratio of 10 between axial
and lateral displacement data [59]. The 𝑤𝑖𝑛𝑐 was assigned three different values of 1, 5 and
10. These weight sets were evaluated using an in silico phantom study as discussed in
section 2.2.2.1.
Table 2-1: Different weight sets used for enforcing tissue incompressibility
Data\Weight Sets

3)

WS1 WS2 WS3

Incompressibility Equation

1

5

10

Lateral Displacement

1

1

1

Axial Displacement

10

10

10

Step 3: Strain Compatibility Enforcement
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The final step in the proposed method is enforcing the tissue strain compatibility [60]. The
equation governing strain compatibility is given below in terms of the strain tensor
components:
𝜕2 𝜀𝑥𝑥
𝜕𝑦 2

+

𝜕2 𝜀𝑦𝑦
𝜕𝑥 2

𝜕2 𝜀𝑥𝑦

− 2 𝜕𝑥𝜕𝑦 = 0

(2-16)

A numerical approximation was derived for this equation using the finite difference
method, which was then applied to all grid points in the FOV, leading to the following
matrix equation:
𝑃𝜀 = 0

(2-17)

Here, 𝜀 is a vector containing lateral, axial and shear strains, and P is a coefficient matrix
containing parameters of the finite difference approximation of the compatibility equation.
Combined with the strains calculated based on the refined displacements obtained in the
previous step, the following system of equations can be obtained.
0
𝑃
[ ] 𝜀 = [ ] → 𝐵𝜀 = 𝑒
𝜀𝑚
𝐼

(2-18)

This equation can be solved using the Polak-Ribiere method to obtain a further refined
estimate of the strain.

2.2.2
2.2.2.1

Method Validation
In-silico Breast Phantom Study

The proposed method was first validated using an in silico breast biomechanical model. To
generate the breast in silico model, a typical breast geometry was segmented from a 3D US
image which captured the entire breast volume, using 3D Slicer (www.slicer.org). To
generate the breast FE mesh, the segmented geometry was processed using IA-FEMESH
(MIMX, Iowa city, IA, USA). A spherical inclusion was defined within the breast mesh to
mimic the breast tumor. For better realism, the breast tissue, including the background and
tumor regions was modeled as hyperelastic material using the polynomial model. The
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hyperelastic parameters of the normal and tumor tissues in the breast were assigned based
on values reported in the literature [55], [61].
For simulating breast compression using an US probe mimicking a typical USE procedure,
ABAQUS FE solver (ABAQUS 2019, Dassault Systèmes Simulia Corp., Johnston, RI,
USA) was used. The probe’s loading was applied using a contact mechanics model
following the master-slave approach. To improve the simulation realism, the contact
problem was carried out in two steps. In the first step, the probe was lowered onto the breast
model until it was in full contact with the surface of the breast. The second step involved
further quasi-static compression to achieve the breast’s desired deformation. After
deforming the breast model, we obtained the displacement field within the mid-plane
beneath the probe. As shown in Figure 2-4b, this mid-plane represents the US FOV.
Consistent with USE, only the displacements pertaining to the second compression step
was considered to mimic the displacement data. To add more realism to the displacement
data obtained from this simulation, white Gaussian noise was added such that the ratio of
noise amplitude of the lateral to the axial directions was 10. The SNR of the noisy axial
and lateral displacement fields were 40 and 13.5, respectively. For validation, we input this
simulated noisy displacement field to the developed algorithm and compared the output
displacement field with the noise free version using the normalized mutual information
(NMI) as similarity criterion. Equation (2-19) shows the formula for calculating this
measurement for two fields of A and B. In this equation, H(A) and H(B) show the entropy
of field and H(A, B) shows the joint entropy of A and B. Utilizing the displacement field
generated in this part, we evaluated and compared the validity of the incompressibility
Equation (2-12) developed based on Boussinesq’s model against the plane strain modelbased incompressibility Equation (2-6).
𝑁𝑀𝐼(𝐴, 𝐵) =

2 ×(𝐻(𝐴)+𝐻(𝐵))
𝐻(𝐴,𝐵)

(2-19)
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Figure 2-4: (a) Part of the breast surface under a rectangular contact pressure of the US
probe and image’s rectangular FOV where at each point of this FOV, the stress values are
calculated by integration of Equations (2-7), (2-8) and (2-9) over the probe’s contact
surface. (b) Part of the breast FE model cut at the spherical tumor region with a rigid US
probe pushing against the breast. The rectangular surface mimics the US FOV. As shown
in the figure, x, y, and z directions are corresponding to lateral, out-of-plane, and axial,
respectively.
To determine a proper weight set of equations among the three candidates given in Table
2-1, we used an ad hoc method whereby the NMI value between the “true” and refined
displacement fields and the number of elements that satisfy the compatibility equation
accurately were evaluated. The best selected weight set candidate was the one that led to
the highest NMI value and largest number of compatible elements.

2.2.2.2

Tissue Mimicking Breast Phantom Study

To evaluate the displacement enhancement, the proposed method was applied to three
separate tissue-mimicking breast phantoms consisting of soft background and stiff tumor
tissues. The first phantom is Breast Elastography Phantom Model 059 (Computerized
Imaging Reference Systems (CIRS, Norfolk, VA, USA). The size, shape, and ultrasonic
characteristics of this phantom mimic that of an average human breast in supine position
accurately while it contains several lesions ranging in size from 3 to 10 mm in diameter.
Two different regions of the phantom, henceforth called Phantom A and B, were tested.
The second phantom, referred to as Phantom C, is a block-shaped phantom with a single
inclusion (CIRS, Norfolk, VA, USA). For data acquisition of the first and second
phantoms, the US probe was controlled with a mechanical device to compress the phantom
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with 0.1 inches steps and the US RF data was acquired using an Antares Siemens system
(Issaquah, WA, USA) and a VF10-5 linear array transducer at center frequency of 6.67
MHz and a sampling frequency of 40 MHz. The last phantom, D, was a breast-shaped
phantom constructed in our laboratory using gelatin and agar dissolved in water [62]. The
RF data for this phantom was acquired using an Ultrasonix RP system (Ultrasonix Medical
Corporation, Richmond, BC, Canada) and a L14-5/38 linear array transducer with a
nominal frequency of 10 MHz at a sampling frequency of 20 MHz. The displacement and
strain fields were initially estimated using GLUE method [31], [32]. We then refined the
displacement and strain fields using the proposed technique, STREAL. To quantify
improvements in the strain images, the following unitless metrics of signal to noise ratio
(SNR) and contrast to noise ratio (CNR) were used:
𝑆𝑁𝑅 =

𝑠̅
𝜎

2
2(𝑠̅̅̅−𝑠
𝑏 ̅𝑡 )

𝐶𝑁𝑅 = √

𝜎𝑏2 +𝜎𝑡2

(2-20)

(2-21)

Here, 𝑠̅ and 𝜎 are the spatial average and variance of a window in the strain image,
respectively. Similarly, 𝑠̅𝑏 , 𝑠̅𝑡 , 𝜎𝑏 , and 𝜎𝑡 are the spatial average and variance of strains of
a window in the target and background areas, respectively. To further evaluate the
performance of the STREAL method, three breast tissue mimicking phantoms were
simulated using ABAQUS FE solver (ABAQUS 2019, Dassault Systèmes Simulia Corp.,
Johnston, RI, USA). The geometries of these phantoms were chosen to be hemisphere
followed by a cylinder, rectangular cuboid, and sole hemisphere with appropriate sizes to
mimic phantoms A/B, C, and D, respectively. Spherical inclusions were placed inside the
generated in silico phantoms consistent with the actual phantoms’ inclusions. The models
were all linear elastic with the same Young’s moduli as the actual phantoms. Quasi-static
stimulations were then applied to the surfaces of the phantoms before the displacement
fields of the mid-plane of the phantoms were computed. Normalized cross correlation
(NCC) was used to compare these fields to the estimated ones using other popular tissue
motion tracking methods of Global Ultrasound Elastography (GLUE) [74] and Secondorder Ultrasound Elastography (SOUL) [81].
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2.2.2.3

Clinical Breast Ultrasound Elastography Case

Further evaluation of the proposed method was carried out using USE data acquired from
two breast cancer patients in accordance with institutional research ethics board (REB)
approval from Sunnybrook Health Sciences Centre, Toronto, Canada (REB PIN: 1994). A
Sonix RP System (Ultrasonix, Vancouver, Canada) and a L14-5/60 transducer with a
nominal frequency of 10 MHz was used to acquire ultrasound B-mode images and RF data
at a rate of 12 frames per second. The RF data were collected at pre- and post- compression
states of a quasi-static stimulation of the breast using the US probe by a trained
sonographer. Similar to the phantom study, initial displacements and strain fields were
estimated using the GLUE method before they were refined using the STREAL algorithm.
SNR and CNR of the strain images before and after using the STREAL algorithm were
calculated for quantitative comparison.

2.3 Results
2.3.1

In silico Breast Phantom Study

The simulated axial and lateral displacement fields in the FOV plane of the in silico breast
phantom, including their noisy counterparts, are shown in Figure 2-5. This figure also
illustrates the refined displacement fields using steps 1 and 2 of the proposed STREAL
method. To show the progressive improvement achieved through each step of the
algorithm, NMI values of images obtained with the noisy images and each of their refined
counterpart is reported in Table 2-2.
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Figure 2-5: Original displacement fields generated from the in silico breast model, their
noisy counterparts, and refined displacement fields after steps 1 and 2 of STREAL
Incompressibility equation was calculated at each point within the FOV using the
displacement data acquired from simulation and based on plane-strain assumption and the
Boussinesq’s derived model. This led to the images shown in Figure 2-6 where visual
inspection shows that the resultant of Figure 2-6 is closer to the ideal uniformly black
region compared to the image in Figure 2-6 which shows large values of incompressibility
equation at the top. Compared to theoretical value of 0 for this equation, the norms of these
images are 32.83 and 14.75 for the plane-strain and Boussinesq’s derived models,
respectively. This indicates that the tissue incompressibility distribution obtained based on
the proposed Boussinesq’s derived model is superior to its plane-strain derived counterpart.
Figure 2-7 also shows the plot of NMI between the “true” and refined axial and lateral
displacement fields against the weight set candidates given in Table 2-1 and the plot of
percentage of compatible FE elements based on a threshold value of 0.02. The plots
indicate that the weight set WS1 leads to the best outcome. Figure 2-7 also shows that the
WS1 set leads to ~20% compatible elements which may seem low; however, it should be
noted that this percentage increases significantly by relaxing the threshold value such that
near compatible elements are included. For example, choosing a threshold value of 0.05
leads to ~60% compatible elements for WS1. However, this choice makes comparing the
different weight sets more difficult as the percentage of compatible elements in different
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weight sets are closer in this case. Finally, Figure 2-8 illustrates the true (generated from
Abaqus), noisy, and refined strain fields using steps 1, 2 and 3 of the proposed method.

Figure 2-6: Incompressibility equation calculated using the simulated displacement data
based on (a) plane strain assumption and (b) semi-infinite medium model. The latter is
closer to uniformly black image (zero field) that represents an ideal incompressible tissue.

Figure 2-7: Evaluation of the weight sets used for enforcing tissue incompressibility in the
in silico phantom study; c) the NMI similarity measure between true and refined
displacements, d) percentage of compatible FE elements.
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Figure 2-8: True and refined strain fields at different stages of applying STREAL
Table 2-2: NMI values of displacement and strain fields generated using the algorithm
steps with corresponding “true” fields in the in silico phantom study
NMI with ground truth (in silico)
Noisy

1.5173

Refined by STREAL

1.7795

Noisy

1.2026

Refined by STREAL

1.7615

Noisy

1.0023

Refined by STREAL

1.3600

Noisy

1.0025

Refined by STREAL

1.2121

Axial Displacement

Lateral Displacement

Axial Strain

Lateral Strain

2.3.2

Tissue Mimicking Breast Phantom Study

Figure 2-9 illustrates the results generated for four tissue mimicking phantom cases, A, B,
C and D. It includes the axial and lateral displacement results generated by the GLUE,
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SOUL, and the proposed STREAL technique. Generally, Figure 2-9 indicates that in
contrast to the axial displacement fields that show some improvement, the lateral
displacement fields are improved substantially as these fields show clear evidence of the
inclusions. Figure 2-10 illustrates the phantom strain images obtained using the GLUE,
SOUL, and proposed STREAL techniques. This figure shows that the proposed method is
capable of generating substantially better-quality axial strain and superior quality lateral
strain compared to both the GLUE and SOUL methods. The calculated SNR and CNRs as
well as the local mean strain values for both background and inclusion areas are presented
in Table 2-3. Overall, the STREAL technique is successful in improving the SNR and CNR
of axial strain images of the phantoms by 59% and 51% compared to the GLUE technique,
respectively. Moreover, compared to the GLUE method, the STREAL technique is even
more effective with lateral strain images of the phantoms with about 127% and 554%
improvement in the SNR and CNR, respectively. Table 2-4 shows the similarity between
displacement and strain fields generated through the in silico simulation of the phantoms
and their counterparts computed using the GLUE, SOUL, and STREAL methods. Once
again, these results indicate that while compared to the GLUE and SOUL methods, the
STREAL method leads to some improvement in the accuracy of axial displacements, it
leads to superior quality lateral displacements. An exception is with Phantom D which is
anticipated as the thickness of the breast phantom was very limited, hence the semi-infinite
medium model was not effective.
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Table 2-3: Similarity between displacement and strain fields generated by the in silico
simulation and counterpart fields computed by the GLUE, SOUL, and STREAL methods
NCC with the generated counterpart using in silico
simulation
GLUE

SOUL

STREAL

Axial Displacement

0.9917

0.9919

0.9925

Lateral Displacement

0.5907

0.3695

0.8881

Axial Displacement

0.9210

0.9200

0.9213

Lateral Displacement

0.4302

0.5183

0.7909

Axial Displacement

0.8887

0.8384

0.8894

Lateral Displacement

0.4944

0.3795

0.6601

Axial Displacement

0.9531

0.8919

0.9643

Lateral Displacement

0.4909

0.4138

0.5234

Phantom A

Phantom B

Phantom C

Phantom D
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Figure 2-9: Axial (I) and lateral (II) displacement fields obtained from GLUE, SOUL, and
the proposed STREAL methods for phantom cases A-D. Note that these results were
obtained after performing the first two steps of the STREAL algorithm since the third step
only applies to strain fields.
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Figure 2-10: Axial (I) and lateral (II) strain images obtained from GLUE, SOUL, and the
proposed STREAL method for phantom cases A-D. Note that the figures show the real
values of axial and lateral strains, and the positive values represent compression. Due to
inconsistency between the lateral strain values of different methods, different color bars
are adjusted for each method to have the best visualization.

2.3.3

Clinical Breast Ultrasound Elastography Case

Figure 2-11 shows a breast B-mode image of the clinical case. The lateral and axial strain
images generated by the GLUE method and the STREAL technique for this clinical case
are shown in Figure 2-12. This figure also includes the results generated by the SOUL
method. As the figure illustrates, improvement of both axial and lateral strains was
achieved by applying the proposed STREAL technique.
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Figure 2-11: B-mode images of clinical case where the read outline shows the tumor area

Figure 2-12: Axial and lateral strain images of the clinical case generated using GLUE,
SOUL, and STREAL techniques. The red outline shows the tumor area based on the Bmode image.
Quantitative assessment based on the bottom rows of Table 2-4 shows that the method
significantly improves the SNR and CNR values of both axial and lateral strain images
compared to GLUE and SOUL methods.
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Table 2-4: Calculated SNR and CNR metrics for axial and lateral strain images of the 4
phantoms
SNR

CNR

Strain Image
GLUE

SOUL

STREAL

GLUE

SOUL

STREAL

Axial Strain

8.7

15.9

18.8

5.0

5.2

10.4

Lateral Strain

2.7

2.5

13.2

0.8

0.8

12.3

Axial Strain

3.9

4.2

7.1

1.1

1.0

2.1

Lateral Strain

1.7

2.1

3.2

1.4

1.2

1.9

Axial Strain

9.1

8.9

9.1

4.5

3.2

4.6

Lateral Strain

2.2

1.6

2.6

1.0

0.8

3.3

Axial Strain

8.5

9.3

11.6

3.6

2.4

3.6

Lateral Strain

3.3

4.2

3.7

0.8

1.2

0.8

Axial Strain

1.98

2.05

2.76

2.35

1.61

3.26

Lateral Strain

1.41

2.18

2.21

0.12

0.09

0.19

Phantom A

Phantom B

Phantom C

Phantom D

Clinical
Case
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2.4 Discussion
In this work, we presented a novel method for computing tissue displacement and strain
fields generated in typical ultrasound imaging. The method was designed for applications
in quasi-static USE, including breast, prostate, and liver elastography. In addition to
enhancement of axial displacement images where the field has already made significant
progress, a major feature of the proposed method is its ability to obtain accurate lateral
displacement and strain images. The proposed method attempts to take full advantage of
available constraints governing the tissue mechanics. In addition to enforcing displacement
field continuity conditions, this technique utilizes tissue biomechanics principles for
further improvement of strain image accuracy. The principles include tissue
incompressibility and displacement compatibility which are incorporated in the model to
generate accurate estimation of both axial and lateral displacement and strain images.
To enforce tissue incompressibility, we developed a method which utilizes the Boussinesq
semi-infinite analytical model to estimate the out-of-plane strain component before its
incorporation in the general tissue incompressibility equation. To our knowledge, we are
the first group to consider an estimate of the out-of-plane strain in tissue 2D motion
tracking pertaining to USE. The method developed using the Boussinesq model assumes
Young’s modulus and Poisson ratio values of 3kPa and 0.495, respectively. The 3kPa is a
widely accepted average value [63], while the 0.495 is also a broadly accepted value which
is consistent with the very high water or lipid content of the breast tissue. Moreover,
sensitivity analysis indicated low sensitivity of generated displacement and strain fields
w.r.t these values. The proposed technique enforces the fundamental displacement
compatibility equation to further enhance the strain field. While other investigators have
utilized this equation to assess the quality of estimated displacement fields [52], to our
knowledge, the STREAL algorithm is the first to incorporate the compatibility equation
for strain field refinement. Unlike other methods where continuity based regularization is
imposed at the RF data processing stage [33], [34], [40], [41], [44], the proposed technique
is formulated to improve previously estimated displacement and strain images irrespective
of their source and imaging modality.
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In breast USE, the breast can be idealized as a semi-infinite medium and out-of-plane strain
can be analytically calculated using the Boussinesq model. We first used this idealization
with synthetic displacement data obtained from a simulated breast after it was
contaminated with realistic noise. The results showed that the method is successful in
almost entirely eliminating the noise. The in silico breast model represents a good breast
model in terms of geometry and material behavior. Hence, the semi-infinite model used to
develop the incompressibility equation in this work is anticipated to be effective with
clinical data as supported by the reported clinical case. The presented formulation involves
weight factors pertaining to axial and lateral data in addition to tissue incompressibility. In
this investigation we attempted to find the optimal set of these factors, however, further
investigation and more rigorous method is required to find a robust set that can be reliably
used in the clinic.
The proposed method was further validated using tissue-mimicking phantoms, including
breast-shaped and block-shaped with one or several inclusions. Figure 2-9 and Figure 2-10
and Table 2-4 indicate that, in all phantom cases, the proposed method produces
substantially better and superior strain images compared to the GLUE technique for the
axial and lateral directions, respectively. Results of the clinical case show that the STREAL
technique can improve axial and lateral strains qualitatively as, compared to the images
produced using the GLUE technique, the tumor area is more distinguishable. The results
also indicate that the proposed method is superior compared to the GLUE technique as it
shows 127% and 554% improvement in the SNR and CNR of the lateral strain images. It
is noteworthy that although the lateral strain images generated using the STREAL
technique are significantly dissimilar to the ones generated using the GLUE and SOUL
methods, the in silico results show that the STREAL technique is more successful in
generating realistic and accurate lateral strain images. By excluding Phantom D that led to
only 14% improvement in the lateral displacement estimation, this conclusion is supported
by the obtained higher accuracy of the displacement images, including average lateral
displacement accuracy improvement over competitor methods of 34% to 46% measured
by image similarity with corresponding ground truth images. Therefore, while the GLUE
and SOUL methods are capable of producing reasonably accurate axial strain images that
can be used for clinical applications, the quality of their lateral strain images are generally
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low. In contrast, the proposed method is very promising in producing accurate lateral strain
images. This can have a significant impact in improving Young’s modulus images
generated using inversion techniques as the image reconstruction is generally known to
involve an ill-posed inverse problem, hence it can benefit substantially from availability of
additional high quality data [86]. Such measured data enrichment can potentially facilitate
the development of more complex elastography techniques targeting reconstruction of
more realistic model (e.g., anisotropic tissue model) parameters.
It is notable that while the results demonstrated very significant improvement in
displacement and strain estimation, higher level of accuracy may be achieved by
considering more realistic breast geometry and improved models to estimate the out-ofplane strain distribution before incorporating in the fundamental incompressibility
constraint. A notable limitation of the proposed method is its foundation on linear elasticity
which assumes small tissue deformation. This implies that it cannot be used for
elastography techniques aimed at reconstructing tissue hyperelastic parameters.
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Chapter 3

3

Enhanced Full-Inversion-Based Ultrasound
Elastography for Evaluating Tumor Response to
Neoadjuvant Chemotherapy in Patients with Locally
Advanced Breast Cancer

A version of this chapter has been submitted as a journal paper for publication in
Physica Medica.

3.1 Introduction
Breast cancer is the second most diagnosed cancer in women, estimated to affect 1 in 8
women during their lifetime [1]. About 10% to 20% of new breast cancer cases are present
with locally advanced breast cancer (LABC) [4]. LABC tumors are usually larger than 5
cm and may include varying extent of skin and/or chest wall involvement [2]. The current
standard treatment for LABC includes neoadjuvant chemotherapy (NAC) to shrink the
tumor and make it operable before removing it surgically using procedures such as
mastectomy [3]. Several studies have reported a significant correlation between patient
response to NAC and improved treatment outcomes including survival metrics [4]–[7].
However, about 30% to 40% of patients do not even partially respond to standard
chemotherapy, while complete response is limited to less than 30% of patients [8]–[13].
Predicting patient’s response early after NAC initiation may enable physicians to offer
treatment adjustments (e.g., modifying regimen, dose and/or sequence of treatment
options) or even switch to salvage therapy for non-responding patients, before it is too late
[14]. Such patient-specific treatment modifications can spare breast cancer patients from
unnecessary side effects and improve their overall treatment outcomes and quality of life.
Current approaches for evaluation of response to NAC aim at detecting changes in tumor
size in response to treatment [15]. They include physical examination or standard
anatomical imaging such as computed tomography (CT), conventional ultrasound imaging,
and magnetic resonance imaging (MRI). Tumor size changes, however, may take several
months to become detectable, and sometimes may not be evident on imaging despite a
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favorable histopathological response to therapy [16]–[18]. As such, none of these
anatomical imaging modalities are routinely used in clinical settings to monitor response
to NAC within the first few weeks after treatment initiation.
To develop more effective monitoring techniques, a number of studies have investigated
different functional imaging modalities for evaluating cancer response to treatment [18],
[19]. Such modalities evaluate physiological, metabolic, and/or molecular changes in the
tumor, potentially enabling assessment of therapy response before a change in tumor size
is detectable on anatomical images. In this context, dynamic contrast enhanced (DCE) MRI
has been investigated to detect early changes in tumor physiology as associated with
angiogenesis and microcirculation in response to chemotherapy [20]–[25]. While it
showed promise for evaluation of breast cancer response to NAC, DCE-MRI is relatively
expensive and requires injection of exogenous contrast agents for each assessment during
the course of treatment. A number of studies have demonstrated the potential of nuclear
medicine imaging including positron emission tomography (PET) for evaluating tumor
response to chemotherapy by detecting early changes in tumor metabolism [26], [27]. It
has been demonstrated that early mean reduction of 2-deoxy-2-[F-18] fluoro-D-glucose
(FDG) uptake measured using FDG-PET/CT is significantly higher in responding tumors
compared to non-responding lesions [26], [27]. PET has also shown potential for early
response assessment in breast cancer patients through tumor cell proliferation assessment
via quantifying 3’-[F-18] fluoro-3’-deoxythymidine (FLT) uptake [28]. These imaging
modalities are, however, not always accessible, often limited in resolution while they need
injection of radionuclide contrast agents, limiting the frequency of scanning patients for
response evaluation during the course of treatment. Quantitative ultrasound (QUS) is
another functional imaging modality that can examine response-related tumor microstructure characteristics [29]–[36]. QUS parameters have shown high sensitivity in
characterizing tumor cell death in response to cancer therapy in preclinical studies [37],
[38]. Clinical studies on LABC patients undergoing NAC also demonstrated that early
changes in QUS parameters after treatment initiation can differentiate patients in terms of
clinical and pathological response and long-term survival [39], [40]. Diffuse optical
spectroscopic imaging (DOSI) is another possible alternative to other breast imaging
modalities. This modality has shown good potential in clinical applications pertinent to
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breast cancer assessment and diagnosis [41]–[43]. This method has been used for
monitoring NAC response in patients with breast cancer by probing changes in tumor
composition, perfusion, and oxygenation [44]–[49]. However, the diagnostic performance
of DOSI was found to be inferior to that of early metabolic response as monitored by FDG
PET/CT in [46]. While DOSI does not require any exogenous contrast agents for imaging,
it is associated with long scan time for reconstructing images with acceptable resolution,
hence it has not been adapted in the clinic as a standard modality.
Several studies have demonstrated considerable correlation between tumor formation and
alteration in tissue biomechanical properties [50]–[52]. Generally, the dynamic nature of
the tissue extracellular matrix (ECM) plays a crucial role in cancer progression [53]. It has
been demonstrated that increasing ECM stiffness as a result of excessive collagen
generation during tumor formation can directly activates biological processes that result in
tumor invasion and metastasis [54]. Moreover, increased collagen content in ECM can
promote tumor progression and invasiveness [55]–[59]. Given that chemotherapy leads to
apoptosis and other forms of cell death in tumor, it is anticipated that ECM composition is
impacted significantly during effective therapy. A manifestation of such alterations is
potentially tissue stiffness reduction. In other words, there is a potential correlation
between chemotherapy response and tumor softening. In a study conducted by Falou et al.,
a commercial ultrasound machine was used for clinical strain imaging of breast tumors in
15 LABC patients before and after the start of NAC [60]. Their results demonstrated that
changes in relative tumor stiffness can differentiate patients in terms of clinical and
pathologic response to treatment as early as 4 weeks after the start of chemotherapy.
However, ultrasound strain elastography lacks accuracy in quantifying tissue stiffness as it
relies on a poor tissue stress uniformity assumption. Recently developed techniques for
ultrasound elastography that are capable of quantifying tissue biomechanical properties
with precise measures such as Young’s modulus can potentially be adapted to monitor the
biomechanical alterations in tumor in response to treatment [61], [62]. Such methods are
anticipated to be capable of more reliable and earlier differentiation between responding
and non-respondent patients after therapy initiation.
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The present study proposes an enhanced full-inversion-based ultrasound elastography
technique to quantify changes in the Young’s modulus of LABC tumors as a measure of
the response to NAC. This technique applies ultrasound radiofrequency (RF) data acquired
via a quasi-static stimulation of breast tissue induced by ultrasound probe to generates
enhanced strain images by enforcing fundamental principles of continuum mechanics. The
enhanced strain images are then input to an iterative inverse finite element (FE) algorithm
to reconstruct the relative Young’s modulus image of the breast tissue. The method was
applied to ultrasound RF data acquired from 25 LABC patients undergoing full course of
NAC before (baseline) and at weeks 1, 2, and 4 after the treatment initiation. The Young’s
modulus ratio of tumor to the surrounding tissue was calculated at different scans and
compared to the baseline for each patient. Patient responses to NAC were determined many
months later using standard clinical and histopathological criteria and applied to evaluate
the efficacy of the enhanced elastography method for early evaluation of therapy response.
The results show a very good potential of the proposed technique in predicting the tumor
response to NAC at week 1 after the start of treatment.

3.2 Materials and Methods
3.2.1

Study Protocol and Data Acquisition

This study was conducted in accordance with the institutional research ethics board
approval from Sunnybrook Health Sciences Centre, Toronto, Canada (REB PIN: 1994).
The study was open to all woman aged 18-85 years, diagnosed with LABC, and scheduled
for NAC followed by surgery. Twenty-five eligible patients were included in the study
after obtaining written informed consent. A core needle biopsy was performed for each
patient to confirm cancer diagnosis. Information pertaining to tumor grade, histology, and
receptor status was also acquired from respective biopsy specimens. For NAC, 14 patients
(56%) received doxorubicin, cyclophosphamide followed by paclitaxel or docetaxel (ACT/D), 2 patients (8%) received paclitaxel and cyclophosphamide (TC), and 9 patients
(36%) received 5-fluorouracil, epirubicin, cyclophosphamide followed by docetaxel (FECD). Furthermore, all patients with HER2+ tumors received tratuzumab. The duration of
chemotherapy for each patient was between three to five months. Pre- and post-treatment
MRI were acquired for each patient before the start of NAC and prior to surgery, which is
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typically done within a month after the completion of NAC, to determine the initial and
residual tumor size.
Using a Sonix RP System (Ultrasonix, Vancouver, Canada), ultrasound B-mode images
and radiofrequency (RF) data were acquired from the patients’ affected breast before
treatment as well as at week 1, week 2, and week 4 after the NAC initiation. A 6-cm-wide
L14-5/60 transducer operating at a nominal frequency of 10 MHz and a frame rate of 12
frame/s was used in this study. Following standardized protocols for data acquisition, all
the ultrasound data were acquired by a trained sonographer while the patients were lying
supine with their arms above their head. The transducer focus for each patient was
determined based on tumor center depth before treatment and it was kept consistent through
the rest of the study. On average, 4 scan planes of the tumor were acquired for each patient
in ~1-cm increments under the guidance of a physician. Raw RF data were acquired at each
scan plane before and after a quasi-static stimulation of the breast by the probe and saved
digitally with 16-bit resolution for use in the enhanced elastography method described later.
The patients underwent surgery after completing the course of NAC and the surgical
specimens were stained with hematoxylin and eosin (H&E) for histopathology. The
histopathology samples were assessed by a board-certified pathologist who kept blinded to
the study results. Patients were categorized into two cohorts of responders and nonresponders using the modified response (MR) grading system described in [63], [64] that
is based on response evaluation criteria in solid tumors (RECIST) [15] and
histopathological criteria [17], [35]. Patients with a MR score of 1-2 (less than 30%
reduction in tumor size) and 3-5 (more than 30% reduction in tumor size or with very low
residual tumor cellularity) were determined as non-responders and responders,
respectively. In keeping with this, 17 and 8 patients in this study were identified as
responders and non-responders, respectively. Table 3-1 summarizes the clinical
characteristics of the patients participated in this study.
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Table 3-1: Participating patients’ characteristics
Characteristics

Mean ± SD / Percentage

Age

51 ± 12 years

Tumor Size (Maximum Diameter)
Initial Tumor Size

5.42 ± 2.25 cm

Residual Tumor Size

2.25 ± 2.87 cm

Histology
Invasive Ductal Carcinoma

88%

Invasive Lobular Carcinoma

4%

Invasive Metaplastic Carcinoma

8%

Molecular Features
ER+

48%

PR+

32%

HER2+

28%

Triple Negative

40%

ER/PR+ & HER2+

16%

ER/PR+ & HER2-

32%

ER&PR- & HER2+

12%

Response
Responders

68%

Non-Responders

32%
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3.2.2

Enhanced Strain Imaging

Axial and lateral displacement fields for each scan plane were estimated using two frames
of ultrasound RF data acquired at two states of tissue pre- and post-mechanical stimulation
with the ultrasound probe. In the first step, an initial estimation of the axial and lateral
displacement fields was obtained using the method proposed in [65] followed by the Global
Ultrasound Elastography (GLUE) method [66]. The resulting fields were then input to the
STrain REfinement ALgorithm (STREAL) [67]–[69]. This algorithm improves the
accuracy of the displacement fields and strain images by imposing continuum mechanics
principles of tissue incompressibility and compatibility through the following steps:
1. Applying Laplacian filtering to smooth the initial displacement fields estimated by
GLUE method.
2. Estimating the ratio of out-of-plane strain to axial strain at each point within the
tissue computational field of view. This estimate is derived from modeling the
breast as semi-infinite medium following the Boussinesq model [68].
3. Enforcing tissue incompressibility equation in 3D using the estimates obtained in
step 2 to refine the axial and lateral displacement fields.
4. Applying finite difference spatial derivative on the refined displacement fields to
generate enhanced images of the tissue axial and lateral strain.
5. Enforcing strain compatibility equation to further enhance the axial and lateral
strain images.

3.2.3

Full Inversion-Based Elastic Modulus Reconstruction

A full-inversion-based quasi-static elastography technique was adapted to reconstruct
relative Young’s modulus image of the breast tissue, using the enhanced strain images
obtained through the methods presented in the previous section as input [61]. The technique
applies iterative algorithm of FE analysis for computing tissue stress distribution resulting
from the quasi-static mechanical stimulation followed by Young’s modulus (E) calculation
using 2D Hooke’s law (Equation (3-1)).
𝜀𝑦𝑦
1
=
𝐸 𝜎𝑦𝑦 − 𝜈𝜎𝑥𝑥

(3-1)

76

In this equation, ν is the tissue Poisson’s ratio which is set to 0.495 according to breast
tissue incompressibility, and ε and σ represent the strain and stress where the subscripts yy
and xx correspond to the axial and lateral directions, respectively. The iterative process of
E reconstruction is stopped when E values of the finite elements stop changing appreciably.
For the stress calculation part of the reconstruction technique, FE analysis was used
through ABAQUS FE solver (ABAQUS/Standard, Dassault Systèmes Simulia Corp.,
Providence, RI, USA). For this analysis, the rectangular field of view of the ultrasound
scan plane was meshed using linear quadrilateral elements developed for plane stress cases.
This assumption was based on the experiment conducted and described in 2.2.1. In the FE
analysis, unlike other techniques that assume ideal unconstrained boundary conditions
along the outline of the field of view, we used experimentally measured prescribed
displacement boundary conditions along the outline. These displacement boundary
conditions were obtained from a subset of the refined displacement data obtained as
described earlier, while the high-quality strain data was used in Equation (3-1) for updating
E in each iteration. Two different methods were used for updating E in each iteration:
1. In the first method, similar to [61], we used Equation (3-1) throughout the
iterations. The Young’s modulus images obtained from this approach are labelled
“axial-strain-based E image”.
2. To take advantage of the enhanced lateral strain, we also used Hooke’s law in
conjunction with the lateral displacements as given in Equation (3-2). In this
method, we used both Equations (3-1) and (3-2) with weight factors of 10 and 1,
respectively, to update E. The Youngs’ modulus images obtained following this
method are labelled “axial/lateral-strain-based E image”. The weight factors were
selected based on previous reports that estimate the signal-to-noise ratio of
ultrasound axial strain images to be typically 10 times higher compared to lateral
strain images [70].
1
𝜀𝑥𝑥
=
𝐸 𝜎𝑥𝑥 − 𝜈𝜎𝑦𝑦

(3-2)
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3.2.4

Data Analysis

Using the B-mode images, the region of each tumor was outlined in each scan plane with
a physician’s guidance. A representative surrounding area of normal tissue was then
selected in each scan for calculating the strain or E ratio of the tumor to surrounding normal
tissue. At each patient’s assessment time, the strain or E ratio was first calculated for each
scan plane and then averaged across all scan planes of the tumor to obtain the average ratio
for the entire tumor volume. For obtaining the average E value within the tumor area in
each scan plane, a Gaussian distribution was fitted to the E values within the tumor region,
and the values associated with the lower 30% of the distribution were removed. This preprocessing step was performed to discard small E values pertaining to tumor heterogeneity
and to obtain a better estimate of the stiff areas within the tumor region. For calculating the
average E value of the surrounding normal tissue in each scan plane, any E value smaller
than 50% or larger than 150% of the average E value of the normal tissue region was also
discarded following the same argument and the findings of [71] on the mechanical
properties of breast tissue samples. The final E ratio of tumor to normal tissue in each scan
plane was then calculated by taking the ratio of the average of the remaining values in each
region. A similar method was used to calculate average strain ratios.
Relative changes in the strain and E ratios from the baseline (pre-treatment scan) were
calculated for each patient at weeks 1, 2, and 4 after the initiation of NAC. Statistical
analysis was conducted using mixed analysis of variance (ANOVA) to assess significance
of the difference in strain or E ratio change after NAC between responding and nonresponding patients. Normality violations in each group of the combination of the two
factors (response, scan time) were checked using the Shapiro-Wilk test. A t-test (two-sided,
95% confidence) was performed to assess if the two cohorts of patients show any
significant difference in the strain or E ratio changes at each scan time (weeks 1, 2, and 4)
compared to the baseline. Receiver operating characteristics (ROC) analyses were
performed to assess the ability of these parameters at different scan times to differentiate
between the response of the two cohorts in terms of the area under the curve (AUC).
Similar analyses were performed on tumor size changes from the baseline measured at each
scan time using the ultrasound images acquired for each patient. The tumor size was
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determined based on the maximum tumor diameter among all the available scan planes to
be consistent with the RECIST criteria.

3.3 Results
Figure 3-1 and Figure 3-2 show representative B-mode, strain and E images acquired
before and at weeks 1, 2 and 4 after the NAC initiation for a responding and a nonresponding patient, respectively. In the responding patient, a continuous reduction in tumor
stiffness compared to the baseline is detectable starting from week 1. The reduction is more
evident at weeks 2 and 4 after the NAC initiation. For the non-responding patient, minimal
changes are observed in tumor stiffness in response to NAC, even at weeks 2 and 4 after
the NAC onset. While possible changes in tumor stiffness after NAC can be detected on
the strain images, such changes are more evident on the E images. Generally, the axialstrain-based and axial/lateral-strain-based E images have similar quality. However, for
some cases the latter show better contrast in identifying tumor and healthy regions. Figure
3-3 demonstrate hematoxylin and eosin (H&E) stained histopathology images of the
surgical specimens acquired for the representative patients. A large residual tumor is
observed in the mastectomy specimen of the non-responding patient. The histopathology
image of the responding patient demonstrates the tumor bed area with chemotherapy effect
and no residual carcinoma. Both images indicate notable heterogeneity within the tumor
region.
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Figure 3-1: B-mode (A), axial strain (B), lateral strain (C) and relative Young’s modulus
images obtained based on the axial strain (D) and based on axial and lateral strains (E)
obtained for a representative responder before and at different times after the NAC
initiation. The axial and lateral strain images were generated using the STREAL technique.
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Figure 3-2: B-mode (A), axial strain (B), lateral strain (C) and relative Young’s modulus
images obtained based on the axial strain (D) and based on axial and lateral strains (E)
obtained for a representative non-responder before and at different times after the start of
NAC. The axial and lateral strain images were generated using the STREAL technique.
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Figure 3-3: Histopathology images of surgical specimens obtained from representative
responding and non-responding patients.
Figure 3-4 demonstrates average changes in the strain and E ratios compared to the baseline
at different times after NAC initiation for the two patient cohorts. According to these plots,
the axial strain ratio decreases over time after week 1 for the responder cohort while it
shows an increase for the non-responder cohort at week 1 with little average changes
afterwards. However, the lateral strain ratio demonstrates minimal changes throughout the
chemotherapy for the responder cohort while showing elevations for the non-responder
cohort. In the plots associated with both versions of the E image, the responder cohort
demonstrates a consistent reduction in the average E ratio, starting with 15-20% decrease
on average at week 1, followed by 25-30% at week 2 and 40-45% at week 4 following the
treatment onset. In contrast, the non-responder cohort shows minimal change in the average
E ratio after the start of the chemotherapy with less than 10% change on average even at
week 4 following the treatment initiation. In summary, the change in E ratio for both
versions of the E images can completely differentiate responders from non-responders as
early as one week after the start of treatment, whereas a clear differentiation cannot be done
based on changes in strain ratio until 4 weeks after the NAC initiation. Figure 3-5 shows
average changes in tumor size from the baseline at weeks 1, 2 and 4 after the treatment
onset. No substantial changes are visible in tumor size to separate the patient cohorts, with
~10% and ~5% average decrease for the responding and non-responding patients at week
4, respectively.
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Figure 3-4: Relative changes in tumor stiffness compared to baseline after the start of NAC
for responding and non-responding patient cohorts, estimated based on axial strain ratio
(A), lateral strain ratio (B), E ratio obtained from the axial-strain-based relative Young’s
modulus image (C), E ratio obtained from the axial/lateral-strain-based relative Young’s
modulus image (D).

Figure 3-5: Relative changes in tumor size compared to baseline after the NAC initiation
for responding and non-responding patient cohorts.
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Table 3-2 shows the results of statistical analysis among the responding and nonresponding patients at different scan times. The results obtained from the mixed ANOVA
test demonstrate a statistically significant difference in changes in the E ratio between the
responding and non-responding patients after the onset of NAC. Such difference is
statistically extremely significant in the E ratio changes estimated using both approaches
(p-value < 0.001). A similar test conducted for the changes in strain ratios and tumor size
demonstrate no significant difference for the lateral strain and tumor size, but an
approaching significant difference (p-value = 0.08) for the axial strain. Conducted t-test
demonstrates a statistically significant difference in the E ratio changes from the baseline
as early as one week after the treatment onset that is maintained at weeks 2 and 4, with
high statistical power. In contrast, no significant difference is observed for changes in the
tumor size or lateral strain ratio at weeks 1 to 4. For the axial strain ratio, a significant
difference is only seen at week 4 after the treatment initiation. Moreover, results of the
ROC analysis demonstrate promising AUCs obtained for changes in the E ratios at weeks
1 to 4 after the start of chemotherapy, and for the axial strain at week 4.
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Table 3-2: Results of statistical analysis obtained for different elastography parameters
acquired from the responding and non-responding patient cohorts at different times after
the NAC initiation. *, †, and ‡ demonstrate statistically significant (p-value < 0.05), highly
significant, (p-value < 0.01), and extremely significant (p-value < 0.001), respectively.

Parameter

Week

Mixed ANOVA

T-Test

(p-value)

(p-value)

1
%∆Tumor-Size

%∆Axial-Strain-Ratio

%∆Lateral-Strain-Ratio

AUC

0.93

0.47

0.63

0.61

4

0.52

0.60

1

0.49

0.64

0.17

0.74

4

0.01*

0.85

1

0.16

0.67

0.82

0.51

4

0.21

0.61

1

0.02*

0.79

<0.001‡

0.85

4

<0.001‡

0.99

1

<0.001‡

0.82

0.02*

0.77

<0.001‡

1.0

2

2

2

0.90

0.08

0.31

%∆E-Ratio
2

<0.001‡

(axial-strain-based E image)

%∆E-Ratio
2

<0.001‡

(axial/lateral-strain-based E image)
4
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3.4 Discussion and Conclusion
This study investigated, for the first time, the application of a novel full inversion-based
ultrasound elastography technique for monitoring tumor response to NAC in LABC
patients. The technique adapted the STREAL method [67]–[69] for enhanced strain
imaging coupled with a novel methodology for reconstruction of elasticity images that
permits accurate quantification of breast tissue relative Young’s modulus. The method was
applied on ultrasound data acquired from 25 LABC patients before and at weeks 1, 2 and
4 after the NAC initiation. Changes in tumor stiffness in response to NAC was quantified
using average E and strain ratios of tumor to surrounding normal tissue obtained at 1, 2 and
4 weeks after the start of NAC initiation. Response of patients to NAC was determined
after completing the course of NAC and surgery using the standard clinical and
histopathological criteria. The criteria were used for evaluating the performance of the
elastography parameters in assessing patients’ response to NAC early after the therapy
initiation. Trend of changes in tumor Young’s modulus among the responding and nonresponding patients indicated a very good correlation with the NAC response. In particular,
while the tumor E ratio demonstrated a considerable and continuous decrease for
responding patients starting at week 1, minimal changes were observed for non-responding
patients even at week 4 after the NAC onset.
Statistical analysis confirmed that the method is successful in differentiating responding
and non-responding patients as early as one week after the NAC initiation. Specifically,
statistically significant differences were observed in E ratio changes between the
responding and non-responding patients at all scans after the therapy onset (Table 3-2).
The results of this statistical analysis are indicative of a substantial improvement compared
to the previous study in which a significant difference (p-value = 0.002) in tumor stiffness
changes was only observed after 4 weeks following the start of treatment when such
changes were estimated using clinical ultrasound strain imaging [60]. The results obtained
in this study with strain images supports the findings of the1212 previous study. Here, a
significant difference (p-value = 0.01) in changes of the axial strain ratios was observed
only at week 4 after the chemotherapy onset. The inferior performance of the strain
compared to the E images in early differentiation of the patients’ response to NAC can be
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attributed to the poor stiffness measure of the strain compared to the tissue Young’s
modulus. Strain image is a true representative of the tissue stiffness only if the stress is
uniformity distributed within the breast tissue while being stimulated mechanically with
the ultrasound probe for strain-based elastography. Due to the breast tissue inhomogeneity
and irregular geometry, and local loading, it is well established that considerable stress
non-uniformity exists within the field of view, hindering the sensitivity of strain images in
estimating tumor stiffness. The full-inversion-based E reconstruction algorithm applied in
this study takes tissue stress non-uniformity into account via iterative finite element
analysis, leading to higher signal-to-noise ratio (SNR) in generated E images, hence higher
sensitivity in quantifying small changes in tumor stiffness compared to strain images. The
statistical analysis on tumor size changes measured using the ultrasound images
demonstrated no significant difference between the responding and non-responding
patients at weeks 1 to 4 following the treatment initiation. This observation is in agreement
with findings of the previous studies in which no statistically significant difference was
evident in tumor size changes measured using MRI [72] or ultrasound [73] 3-4 weeks after
the start of chemotherapy.
The enhanced axial and lateral strain images obtained using STREAL were utilized to
generate two versions of E images. The first version of E images was reconstructed using
the enhanced axial images only, while the second version also took advantage of the
enhanced lateral strain images for generating E images with higher quantitative accuracy.
The quality of these images was generally comparable, but in some cases the E images
reconstructed based on both the axial and lateral strain images led to better visualization of
the tumor region compared to those generated based on the axial strain only. Similarly, the
trends of changes in the tumor E ratio measured based on these elasticity images were
similar over the course of treatment in each response cohort. However, the E ratios
associated with the E images generated based on both the axial and lateral strain images
provided a relatively better separation between the two cohorts at weeks 1 and 4 after the
NAC initiation. In particular, a statistically extremely significant (p-value < 0.001;
statistical power = 98%) versus significant (p-value = 0.02; statistical power = 83%)
difference was observed in the E ratio changes measured at week 1 using the E images
reconstructed based on the axial and lateral strain images, and axial strain images,
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respectively. The results of ROC analysis for both these methods demonstrated a relatively
high AUC for NAC response prediction at week 1 after the treatment onset. These
observations support the findings of a very recent study in which ultrasound shear wave
elastography was applied to measure changes in tumor Young’s modulus in breast cancer
patients undergoing NAC [73]. In that study, changes in tumor Young’s modulus were
quantified at weeks 3 and 6 after the NAC initiation, where statistically (highly) significant
differences (p-value = 0.02 and 0.001) were observed between the patient cohorts with
pathological complete versus non-complete response. The findings of this study encourage
future studies to investigate the efficacy of the ultrasound shear wave elastography in
differentiating the response cohorts at weeks 1 and 2 after the NAC initiation, based on the
measured changes in tumor stiffness.
In conclusion, this study demonstrated a very good potential for the proposed full
inversion-based ultrasound elastography technique in assessing and predicating tumor
response to NAC in LABC patients as early as one week after the NAC initiation. Early
prediction of neoadjuvant therapy response for these patients potentially facilitates
treatment adjustments by clinicians on an individual patient basis. A personalized paradigm
for breast cancer therapeutics is anticipated to improve the overall therapy outcome,
survival, and quality of life for the patients. This study, therefore, is a step forward towards
precision oncology and tailoring chemotherapies for breast cancer patients. Studies
involving larger patient populations are, however, required to further evaluate the efficacy
and robustness of the technique.
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Chapter 4

4

Conclusions and Future Work

4.1 Conclusions
In this study, first, an enhanced ultrasound elastography technique was proposed and
rigorously validated using in silico and tissue-mimicking phantom, and clinical studies.
This technique utilizes two tissue mechanics-based principles of tissue incompressibility
and strain compatibility. The more accurate displacement and strain fields can then be fed
into any ultrasound elastography framework to estimate tissue mechanical properties.
These techniques can be employed for early detection and identification of soft tissue
cancer based on the notion that tissue mechanical properties change as a result of cancer.
These tissue mechanical properties can provide useful information for cancer detection and
assessing its progression while a more accurate estimate of these properties obtained
through our enhanced technique can be used in conjunction with other clinical data and
detection methods for example other medical imaging techniques, histopathology results,
etc. to improve clinical outcome and results. Displacement fields obtained using the
aforementioned displacement enhancement technique was used in an unconstrained
inverse finite element framework to estimate tissue Young’s modulus for LABC patients
who were prescribed chemotherapy before a mastectomy. Using this method, the stiffness
ratio of the patients’ tumors was monitored throughout chemotherapy. The purpose of this
study was to find a correlation between the change in the tumor’s Young’s modulus and
patients’ response to chemotherapy. These investigations were presented in two chapters
of this dissertation. The primary research contributions and details of the results for each
chapter are summarized below.

4.1.1

Chapter 2: A Novel Tissue Mechanics-based Method for
Improving Tissue Displacement and Strain Estimation in
Breast Ultrasound Elastography

In this chapter, a novel method for refining tissue displacement and strain fields generated
in conventional quasi-static ultrasound imaging was presented. This method involves three
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main steps of smoothing displacement field using second order derivative-based
regularization, further refining them using tissue incompressibility equation, and finally,
refining the acquired strain fields using strain compatibility equation. Additionally, a
Boussinesq semi-infinite analytical model was used for estimating the out-of-plane strain
which is needed for the tissue incompressibility equation. To our knowledge, this has never
been done before in the literature. Validation of this method was done using a set of in
silico and tissue-mimicking phantom, and clinical studies. All these studies showed that
this method is capable of improving displacement and strain fields specially in the lateral
direction. Based on these validations, the proposed method appears to be very effective in
producing improved estimate of tissue displacement and strain images. Once again,
compared to improvement of the axial displacement and strain components, the
improvement is highly remarkable for the lateral component which had not yet been
ameliorated in the literature.

4.1.2

Chapter 3: Enhanced Full-Inversion-Based Ultrasound
Elastography for Evaluating Tumor Response to
Neoadjuvant Chemotherapy in Patients with Locally
Advanced Breast Cancer

In this chapter the application of a novel full inversion-based ultrasound elastography
technique for monitoring tumor response to neoadjuvant chemotherapy (NAC) in locally
advanced breast cancer (LABC) patients was investigated. The novelty of technique mostly
relates to adapting the STREAL method, described in Chapter 2, for refining displacement
and strain data before generating Young’s modulus (E) images through an inverse finite
element (FE) based reconstruction framework. These images were generated for 25 LABC
patients who underwent full course of chemotherapy at weeks 1, 2, and 4 as well as before
the start of treatment. The stiffness of tumor was then assessed and monitored based on
these Young’s modulus images and the boundaries of tumor which were determined by the
B-mode images counterpart. Based on the response of each patient which had already been
determined after completement of NAC and surgery using the standard clinical and
histopathological criteria, a very good correlation between the change in tumor stiffness
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and final response to NAC was observed. Specifically, statistical analysis confirmed that
using the trend of change in tumor stiffness based on generated E images, the responder
and non-responder patients could be differentiated as early as 1 week after the start of
treatment. This is while such early differentiation could not be found through neither
monitoring tumor diameter nor tumor stiffness based on strain images. In conclusion, this
study demonstrated a very good potential for the proposed full inversion-based ultrasound
elastography technique in assessing and predicting tumor response to NAC in LABC
patients as early as one week after the NAC initiation. Early predication of NAC response
for these patients potentially facilitates treatment adjustment by clinicians on an individual
patient basis. A personalized paradigm for breast cancer therapeutics is anticipated to
improve the overall therapy outcome, survival, and quality of life for the patients. This
study, therefore, is a step forward towards precision oncology and tailoring chemotherapies
for breast cancer patients.

4.2 Future Directions
While the proposed investigations demonstrated very promising results in assessing and
validating the developed technique namely STREAL, further investigation with several
clinical cases is necessary for more rigorous assessment of the method’s performance in
the clinic. Furthermore, there proposed methods involve some limitations which provide
opportunities for further enhancement.
Using an analytical model based on Boussinesq semi-infinite equations for estimating outof-plane strain is a novel and effective method for improving the accuracy of enforced
incompressibility equation for refining axial and lateral displacement fields. However, this
analytical model does not consider specific geometries of different breasts. An ongoing
project in our research lab has been dedicated to address this issue with the aim of
considering patient specific breast geometry.
STREAL method can be applied on any previously generated displacement field from
quasi-static ultrasound elastography of soft tissues, including breast, prostate, and liver
elastography. While we showed efficacy of this method in breast elastography application,
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assessing its performance in elastography of other organs is encouraged. It is noteworthy
that since this method is based on particular assumptions regarding the geometry and tissue
mechanics, the applicability of these assumptions in the organ of interest should be
examined first.
One other potential investigation on STREAL would be applying STREAL on less
regularized displacement fields to assess the level of sensitivity of STREAL to its input.
This investigation has already been started in our labs. The results have been promising so
far, indicating that STREAL can improve even low-quality displacement fields.
In Chapter 2, two variants of E images based on different weights for two different
equations derived from Hooke’s law were generated and assessed for monitoring patients’
response to NAC based on their tumors’ stiffness. While the performance of both these
variants were perceived to be similar, further investigation on the optimum weights for
these variants is recommended. Moreover, studies involving larger patient populations are
required to further evaluate the efficacy and robustness of the technique.
In quasi-static ultrasound elastography, the ultrasound RF data which are collected
throughout the stimulation of tissue consist of several number of frames. The quality of
displacement fields, strain images, and Young’s modulus images depend highly on how
the tissue is being deformed. An important aspect in generating an accurate elastogram is
to find the best pair of RF frames that corresponds to a suitable tissue deformation. One
major bottleneck of quasi-static ultrasound elastography is to find this optimum frame pair.
In this work, this has been done through an ad-hoc procedure in which the fields were
assessed visually by an expert researcher. As a future work, a systematic and automatic
method potentially based on principles of tissue mechanics can be developed for efficiently
finding the proper frame pairs for ultrasound elastography in any ultrasound RF data.

4.3 Closing Remarks
Ultrasound elastography has emerged to be a potential tool for tumor localization and
classification, assessment of cancer progression, and diagnosis of cancer in soft tissues,
including breast, prostate, and liver. While this technique is clinically acceptable,
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inexpensive, and easily accessible throughout the world, it still can be considered to be
nascent while it has a lot of potential for further improvement. Acquiring accurate
displacement fields specially in lateral direction in quasi-static ultrasound elastography has
always been a challenge. This challenge was exquisitely addressed in this research by
incorporating tissue-mechanics based principles. As an application, developing such
technique further has helped us to assess the potential of ultrasound elastography in
evaluating breast cancer progression. Our developed technique and primary results show
great potential in clinical settings. However, further clinical studies are required to assess
the accuracy and reliability of the proposed technique.
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